{
  "title": [],
  "摘要": [],
  "研究背景": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "研究背景"
      ],
      "chosen": false,
      "text_content": "1.1 研究背景",
      "children": [
        {
          "type": 1,
          "outLvl": "",
          "score": 0.25083237266915115,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.24129312895783991,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "创新在国家经济发展中的作用已越来越明显，随着经济全球化的发展，科技创新和技术进步提供的生产率将日益成为决定一个国家、一个行业、一个公司竞争实力的决定性因素。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.009539243711311261,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "只有创新才能立于不败之地，要想保持不败，唯一的办法就是不断创新。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 1.4259274635928751,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.40955535080609223,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "重视研发投入是提高创新能力的重要手段，提高研发投入推动科技创新已成为国家重要发展战略。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.4049670338101831,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "《国家“十二五”科学和技术发展规划》将提高研发投入强度、促进科技与经济紧密结合作为具体发展目标，力争到2015年全社会研发经费与国内生产总值的比例提高到2.2%，全国技术市场合同交易总额达到8000亿元，高技术产业增加值占制造业增加值的比重达到18%。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6114050789765998,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "在这场科技创新浪潮中，企业是最核心和活跃的主体。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 1.2416828032229104,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6445836560085332,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "8687亿元，各类企业经费支出为6579.3亿元，企业经费支出占全部经费支出的75.7%。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.5970991472143771,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "越来越多的企业认识到，在市场经济条件下，只有不断创新，提升核心竞争力，才能确保自己的产品和服务在市场上长盛不衰。"
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "1.1.1 我国研发投入现状",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.46666105775245714,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3225697533531704,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "1.研发经费支出情况。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.14409130439928672,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "如下表1.1所示：从R&amp;D经费支出总额来看，2008-2012年我国R&amp;D经费支出不断增长，从2008年R&amp;D经费支出不到5000亿元增长到2012年R&amp;D经费支出超过10000亿元，翻了一倍还要多。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.18172874777898956,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0020981183155897713,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "18.55%外，每年R&amp;D经费增长幅度都超过了20%，且都超过了当年GDP增长速度。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08982549188800959,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从R&amp;D经费支出强度（R&amp;D经费支出相当于国内生产总值的比重）来看，2008-2012年，R&amp;D经费支出强度不断增加，由2008年的1.47%一直增长到2012年的1.98%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08980513757539021,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "但R&amp;D经费支出强度增长率较低，除2008年达15.65%外，其余几年增长率都保持个位数字增长且都低于当年GDP增长速度。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5464984374092512,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5464984374092512,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研发经费支出数据表明，多年来，我国科技经费投入一直保持稳定增长。国家财政科技支出稳步增加，研究与试验发展（R&amp;D）经费投入力度加大，研究与试验发展"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.6013962127597607,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3001927596577911,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "（R&amp; D）经费投入强度不断提高。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3566541448839314,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "然而，与发达国家相比，我国研发支出强度方面仍显不足。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.48019721141474064,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "例如，2010年日本和德国研发强度分别为3.26%、2.82%，而同期我国研发投入强度为1.47%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.46435209680329775,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "我国在研发投入强度方面仍需继续加强，提高R&amp;D经费支出占国内生产总值的比重，加强科技创新能力仍是我国未来很长一段时间的发展方向。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.2946192203262433,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2946192203262433,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表1.1  我国R&amp;D经费支出情况一览表"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年度指标', '2008', '2009', '2010', '2011', '2012'], ['R&amp;D 经费支出 （亿元）', '4616.00', '5802.11', '7062.58', '8687.00', '10298.41'], ['R&amp;D 经费支出强度 %)', '1.47', '1.70', '1.76', '1.84', '1.98'], ['R&amp;D 经费支出增长率（%）', '24.41', '25.70', '21.72', '23.00', '18.55'], ['R&amp;D 经费支出强度增长率 %)', '5.00', '15.65', '3.53', '4.55', '7.61']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.016340101824812447,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.016340101824812447,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据来源：中华人民共和国统计局网站www. stats. gov. cn《中国统计年鉴2013》"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7491021345852644,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5473340867939815,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.研发人员投入情况。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.13769999299335606,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "如下表1.2所示：从R&amp;D人员总量来看，2007-2011年我国R&amp;D人员总量不断增长，从2007年R&amp;D人员总量173.6万人，以每年20-30万的数量不断增长，到2011年R&amp;D人员总量已达288.3万人。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.011887489879749785,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "五年间R&amp;D人员总量增加了100多万。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.05218056491817717,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2007-2011年R&amp;D人员总量增长率都保持了10%以上的增长率，且都超过了当年就业人员增长率。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年的35.28%。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.8242269583079038,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.22145047357024836,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "相关数据显示：2007-2011年全球R&amp;D人员总量年均增长率为3.7％，我国R&amp;D人员同期年均增长率为13.5％，是R&amp;D人员增长率最高的国家。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.24210619529678337,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "然而，2011年我国每万就业人口中R&amp; D人员数量只有37.7人年，美国（约136）、日本（145）、韩国（138）和俄罗斯（119）等许多国家均数倍于我国。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.36067028944087204,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综合以上数据表明，多年来，我国科技人力资源与研发人员总量一直稳定增长，但科技人力投入强度仍需进一步改善。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.43374114873242187,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.43374114873242187,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表1.2  我国R&amp;D人员投入情况一览表"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年 度指标', '2007', '2008', '2009', '2010', '2011'], ['R&amp;D 人员总量(万人年)', '173.6', '196.5', '229.1', '255.4', '288.3'], ['R&amp;D ', '23.05', '26.01', '30.22', '33.56', '35.28'], ['R&amp;D ', '15.50', '13.19', '16.59', '11.48', '12.88'], ['R&amp;D 人员投入强度增长率（%）', '15.02', '12.84', '16.19', '11.05', '5.13']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.017178355900517677,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.017178355900517677,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据来源：中国科技统计网www. sts. org. cn《中国科技统计数据2012》"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "1.1.2 我国医药制造业在整个高技术产业中研发投入情况",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.24733652495484992,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.24733652495484992,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "高技术产业是国民经济的战略性先导产业，发展高技术产业对于加强科技对经济支撑作用，推进产业结构调整和转变经济发展方式意义重大。目前，我国高技术产业"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.34948498891819396,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.17677853295465204,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "主要包括航空航天器制造业、电子计算机及办公设备制造业、电子及通信设备制造业、医疗设备及仪器仪表制造业、医药制造业。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.17270645596354192,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "然而，高技术产业内部各行业之间R&amp;D经费支出仍存在很大差异。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.538041624030861,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08614620435533459,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "如下表1.3所示：在R&amp;D经费支出方面各行业差异巨大。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11581739971318225,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年全部高技术产业R&amp;D经费支出总额为1440.9亿元，电子及通信设备制造业R&amp;D经费支出为790.5亿元，占经费支出总额的一半以上，其他行业仅为一二百亿元，行业R&amp;D经费支出差异明显。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.07908505556696972,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "在R&amp;D经费支出与工业总产值比重方面各行业差异依然巨大。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08406828515611814,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "航空航天器制造业比值最高，比例达7.82%，远高于全部高新技术产业R&amp;D经费支出与工业总产值比重（1.63%）。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.1729246792392563,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "医药制造业R&amp; D经费支出与工业总产值比重为1.41%，仅高于电子计算机及办公设备制造业R&amp;D经费支出与工业总产值比重，排在高技术产业内部各行业的倒数第二位。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.09457659162480894,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.09457659162480894,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表1.3  高技术产业R&amp;D 经费支出及其与工业总产值之比（2011）"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['指标行业', 'R&amp;D 经费支出(亿元)', '与工业总产值之比%)'], ['全部高技术产业', '1440.9', '1.63'], ['航空航天器制造业', '149.6', '7.82'], ['电子计算机及办公设备制造业', '158.1', '0.75'], ['电子及通信设备制造业', '790.5', '1.82'], ['医疗设备及仪器仪表制造业', '131.5', '1.91'], ['医药制造业', '211.3', '1.41']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.017178355900517677,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.017178355900517677,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据来源：中国科技统计网www. sts. org. cn《中国科技统计数据2012》"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.22034689243711408,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.22034689243711408,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "下图1.1，从直观上更形象的说明了各行业R&amp; D经费支出与工业总产值比重差异。综合以上图表数据表明，高技术产业R&amp;D经费支出差异巨大，尤其是医药制造"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.190771408470508,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.004032757893887889,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "业R&amp; D经费支出与工业总产值比重过低。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08476612474361389,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "《国家“十二五”科学和技术发展规划》指出实施国家科技重大专项是科技工作的重中之重，并将重大新药创制作为重大科技专项之一。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2374054627314631,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "明确提出针对满足人民群众基本用药需求和培育发展医药产业的需要，突破一批药物创制关键技术和生产工艺，研制30个创新药物，改造200个左右药物大品种，完善新药创制与中药现代化技术平台，建设一批医药产业技术创新战略联盟，基本形成具有中国特色的国家药物创新体系，增强医药企业自主研发能力和产业竞争力。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8645670631015433,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "因此，我国医药制造企业应增加R&amp;D经费支出，提高R&amp;D经费支出及其与工业总产值比重。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": ""
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "8"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "7"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "6"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "5"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "1"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "0"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.1583689089050706,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.1583689089050706,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "全部高技术产业 航空航天器制造业"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.1273170600304695,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.1273170600304695,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "电子计算机及办公设备制造业"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.10399111639502084,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.10399111639502084,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "电子及通信设备制造业"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.2707692345675694,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2707692345675694,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "医疗设备及仪器仪表制造业医药制造业"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.09457659162480894,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.09457659162480894,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "图 1.1  高技术产业R&amp;D经费支出及其与工业总产值之比"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.017178355900517677,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.017178355900517677,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据来源：中国科技统计网www. sts. org. cn《中国科技统计数据2012》"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "1.1.3 研发投入国际间的比较",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7786062945900456,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3368649310235886,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "1.我国研发经费支出总额及增长速度都位居世界前列。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.15125084937652114,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2012年我国R&amp;D经费规模首次突破万亿大关，达到10298亿元，按2012年平均汇率折算为1631亿美元（1美元兑6.312元）。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.02592822993746791,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "与此同时，R&amp;D经费继续保持高速增长，2008—2012年平均增长速度达到29.1%（可比价），增速位居全球前列。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.26456228425246797,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "而同一时期，受国际金融危机影响，主要发达国家对国内R&amp; D活动的经费投入则呈现增速放缓态势。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.37741684439039325,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.003455570693558926,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.5%；2010年与2008年相比，日本R&amp;D经费下降约12%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.04231901020897104,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "截至2011年，各主要国家占全球R&amp;D比重为：美国占31.2%，日本占14.8%，中国占10.1%，德国占7.7%，法国占4.7%，英国占3.2%，韩国占3.0%[1]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3316422634878633,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据表明：我国研发经费支出总额及增长速度都位居世界前列。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.4038469903434548,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.33988187306835665,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.我国研发人员总量及增长速度都位居世界前列。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.06396511727509814,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年全球R&amp;D人员总量（根据全球41个主要国家和地区的统计，这41个国家和地区的科技资源总量占全球总量的98%以上）约为1138万人年，比上年增长3.7%。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.03152694562626719,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.03152694562626719,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010年的3.5%, 2011年有所回升。2007-2011年全球R&amp;D人员总量年均增长率为"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.16210241613282955,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.16210241613282955,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3.7％，我国R&amp;D人员同期年均增长率为13.5％，是R&amp;D人员增长率最高的国家。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.49639952171202495,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.14916639647272428,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年我国R&amp;D人员总量占世界总量的25.3%，继续稳居世界第一位。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.00878778752983465,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "美国R&amp;D人员总量估计约占世界总量的17%，居第二位。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.003786132176834654,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "日本、俄罗斯、印度、德国、法国、英国、韩国和巴西分别位居第三到第十位[2]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.33465920553263134,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据表明：我国研发人员总量及增长速度都位居世界前列。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.646785868658569,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3747838719161863,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3.研发经费投入强度大幅增长，但与发达国家仍有较大差距。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2765727380674004,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "近年来，我国R&amp;D经费投入强度持续呈现逐年上升的趋势。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0706410708315365,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2008-2012年，R&amp; D经费支出强度不断增加，由2008年的1.47%一直增长到2012年的1.98%，年均增长7.46%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2022878418441094,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "但同期日本、美国、德国的研发强度分别为3.39%、2.77%、2.88%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2647651602556092,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "尽管首次超过欧盟国家1.94%的平均水平，但我们应理性认识到这是因为扩大后的欧盟中一些新成员国的研发投入强度较低，如克罗地亚只有0.75%，整体拉低了欧盟的这一数据。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.4577351857437272,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "因此，我国研发强度仍需不断提高。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 2.9402811407181892,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3783342106104085,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.研发人员投入强度在全球仍处于落后位置。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.48232997779385495,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "每万就业人口中R&amp; D人员数量、每万就业人口中研究人员数量等指标是反映一个国家研发人员投入强度的重要指标。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.18621027761240827,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "虽然，我国R&amp;D人员总量已经稳居世界第一位。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3461771027456646,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "但按人口或劳动力人口平均计算，我国研发人员投入强度在全球仍处于落后位置。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.226721579912168,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年我国每万就业人口中R&amp;D人员数量只有37.7 人年，美国（约136）、日本（145）、韩国（138）和俄罗斯（119）等许多国家均数倍于我国。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.29848941798185014,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年我国每万就业人口中R&amp;D研究人员数量只有17.2人年，美国为101、日本为104、韩国为109、俄罗斯为63，甚至还低于土耳其（27）。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.33266623246843197,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "R&amp;D人员中研究人员所占比重指标反映了一个国家研发人员队伍的质量。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3152743696495153,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年我国R&amp;D研究人员占R&amp;D人员总量的比重为45.7%，发达国家这一指标普遍在60%以上。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3740779719438874,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据表明：研发人员投入强度在全球仍处于落后位置。"
                }
              ]
            }
          ]
        }
      ]
    }
  ],
  "研究目的": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "研究目的"
      ],
      "chosen": false,
      "text_content": "1.2 研究意义",
      "children": [
        {
          "type": 1,
          "outLvl": "",
          "score": 1.524297055763645,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7859380258164288,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "医药制造企业研发投入与企业绩效关系研究具有重要的理论意义和现实意义。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7383590299472164,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "一方面，本文从医药制造企业角度研究研发投入与企业绩效关系，从微观层面研究研发投入绩效，扩大了该领域的研究角度；另一方面，有助于企业更好地认识研发投入与企业绩效之间的关系，从而做出更加科学的研发投入决策。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 2.5789266387261724,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "1.理论意义。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6984558680695503,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "目前，国内外对研发投入绩效的研究主要从国家或地区角度进行，很少从企业层面进行分析，并且多数将研究重点放在定性描述和理论探讨上，尤其是我国缺乏对具体样本数据的实证分析。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.635095249263594,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "近年来，我国虽然对研发投入绩效的实证研究开始展开，但对于研发投入与企业绩效的相关性研究并未取得一致结论.。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.462228766768362,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "同时，对于研发投入的滞后性研究较少。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.783146754624666,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本研究采用实证研究方法，探究医药制造企业研发投入与企业绩效相关性，并对研发投入产出的滞后性进行探索性研究，这对于进一步丰富和完善我国相关领域的研究具有重要意义。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.7536172579039878,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 8.849169639409926e-05,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.现实意义。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7535287662075937,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "从应用价值来看，本文通过对医药制造企业研发投入与企业绩效相关性实证分析，揭示医药制造企业研发投入与绩效间的相关关系及其对企业发展的贡献，促使企业从直观上对研发活动有更加正确的认识。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.820457474227478,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.5773422749113031,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "活动的重视，加大研发投入，增强企业创新能力，提高核心竞争力。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.24311519931617492,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "这对于推动医药制造业快速健康发展具有重要意义。"
            }
          ]
        }
      ]
    }
  ],
  "研究综述": [
    {
      "type": 0,
      "outLvl": "0",
      "score": 0.0,
      "selected": false,
      "part": [
        "研究综述"
      ],
      "chosen": false,
      "text_content": "第二章  理论基础及文献综述",
      "children": [
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "2.1 相关概念的界定",
          "children": [
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.1.1 医药制造业",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 5.214426524434395,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.1704180212070577,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "医药制造业就是指原料经物理变化或化学变化后成为了新的医药类产品，包含通常所说的中西药制造，兽用药品还包含医药原药及卫生材料。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5385367354420045,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "根据国民经济行业分类(GB/T 4754-2011)，医药制造企业包含七个大类：化学药品原料药制造、化学药品制剂制造、中药饮片加工、中成药生产、兽用医药制造、生物药品制造、卫生材料及医药用品制造。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6600778215278233,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "目前，我国医药制造业还存在以下问题：一、医药制造企业总体创新能力有限。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.16169985975954704,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "创新是医药行业的命脉，各种新型疾病的出现以及细菌和病毒的变异需要医药产品的不断创新研发。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7400546131842822,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "然而，由于医药行业研发活动具有“高投入、高风险、周期长”的特点，国内很多医药制造企业为了规避研发风险从而减少对新药物的研发投入。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.24514694144462773,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "相关数据显示，发达国家医药企业将销售额的10%-20%用于新药研究与开发，其研制成功一种新的化学合成药耗资2-3亿美元以上。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.15046006905235387,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "我国医药企业规模相对较小，很难依靠自身资金实现新药物的开发。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6363721238079363,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "二、医药制造企业以普药生产为主，技术含量低。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.0780764871810695,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "普药，是指较为普通的药物，具有临床应用普遍、疗效确切、用量较大、价格较低的特点，并且大都为国家基本药物。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5928479532508413,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "与新药相比，虽然普药技术含量低，经济附加值低，但是规避了药物研发风险，也不需要企业大量的研发资金，因此很多缺乏资金实力的医药制造企业倾向于生产此类药物。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "三、缺乏自主知识产权的药品。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6250919670735282,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "我国医药制造企业发展起步较晚，很多药品直接从国外引进后进行仿制生产，缺乏自主知识产权。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6156439315033227,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "同时，由于医药制造企业自身资金实力不足，医药产品研发风险大等原因，从而导致对新药研发投入不足，进而导致拥有自主知识产权的药品缺乏。"
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.1.2 研究与开发",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.5302641111285973,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3105326652087415,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "研究与开发在《牛津现代高级英汉双解词典》中的解释为：研究是指为了发现新事实，获得更多附加信息而进行的调查（Investigation undertaken in order to discover new facts, get additional information, etc）。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.21973144591985583,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "开发是指一种将现有知识与新的研究成果结合起来的技术活动，它与研究有着完全不同的性质（To bring from latency to or toward fulfillment）。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.678334391717633,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.678334391717633,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "通常认为研究分为基础研究和应用研究。基础研究是指以发现新知识为目的的研究，它与实用几乎没有直接的联系，一般企业是不参与这类研究活动的；应用研究是"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.863877851985924,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.44073237910975566,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "把新发现的知识和已经存在的知识结合起来，探讨其对某种应用的可能性，其中有一部分企业是参与的。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6183580957688742,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "开发是指将应用研究应用于最终目标的产品，证实其实用性，直至达到商业化，它主要是由各个企业单独进行的。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.8047873771072943,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "因此，医药制造企业所进行的研发实际上就是应用研究和开发活动，不涉及基础研究的内容。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.2901166007298391,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2901166007298391,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "《国际会计准则第38号——无形资产》指出研究和开发的定义是：研究是指为获取并理解新的科学或技术知识而进行的独创性的、有计划的调查活动；开发是指在进行商业性生产或使用前，将研究成果或其他知识应用于某项计划或设计，以生产出新的或具有实质性改进的材料、装置、产品等活动。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.33846781682951194,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.33846781682951194,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "美国财务会计准则指出研究和开发的定义是：研究的目的是发现新知识，并有计划的进行探索调查，希望这些新知识对开发新产品、新服务、新的技术有帮助；开发是指将研究的发现的新知识转变为方案或设计，并投入到具体的运营中去，从而生产出新的产品。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.8484194769227729,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.27717418640233243,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "我国2006年发布的新准则将研究开发项目的支出，分为研究阶段支出与开发阶段支出。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.25171005956744713,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "其定义为：研究是指为获取并理解新的科学或技术知识而进行的独创性的有计划调查。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.31953523095299324,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "研究阶段是探索性的，为进一步开发活动进行资料及相关方面的准备，己进行的研究活动将来是否会转入开发、开发后是否会形成无形资产等均具有较大的不确定性；开发是指在进行商业性生产或使用前，将研究成果或其他知识应用于某项计划或设计，以生产出新的或具有实质性改进的材料、装置、产品等。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.33721752054308907,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.33721752054308907,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "综合分析，关于研究和开发的含义各国基本取得了一致的意见，研究与开发可以分为两个既相互联系又相互独立的两个阶段，研究仅是指应用研究的范畴，开发是将研究成果用于生产，是在研究的基础上，继研究活动之后的行为。"
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.1.3 研发费用",
              "children": [
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.1.3.1 研发费用的定义",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.4890757845803726,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.3325135378375163,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "在研究、开发活动中所发生的相关费用，称为研发费用[3]。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.15656224674285626,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "在各国的财务会计准则中，关于研发费用的定义有所差异。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.446090682610463,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.26319425732754137,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "《国际会计准则第9号——研究与开发费用》中规定：研发费用既包括直接计入研发活动的费用，也包括以合理的基础分配计入研发活动的费用。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.1828964252829216,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "研发费用具体包括：研发技术人员的工资和其他有关的费用；研发的固定资产折旧费；研发活动中耗用的材料和劳务费；与研发有关的间接费用以及其他费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.2299068073022497,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.2299068073022497,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "美国《财务会计准则第2号公告——研究与开发费用》对研发费用做出了界定，它与国际会计准则有相似之处，研发的成本要素具体包括：人员；材料、设备和设施；劳务合同以及间接成本；外部购入的无形资产。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6042265627654335,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6042265627654335,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "我国《企业会计准则——无形资产》涉及了研发费用问题，但没有指明研发费用具体包括哪些，仅指明了归集的期间。我国财政部门在会计准则中有明确的规定，企业研发项目研究阶段的支出，在费用发生时就应计入当期损益，无法区分研究阶段支出和开发阶段支出的，也将计入当期损益，而开发阶段的支出，确认为无形资产时应满足下列各项："
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.06409061267856103,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.06409061267856103,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "1.该无形资产完成后在使用或出售时具有可行性。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.06135379439420484,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.06135379439420484,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "2.该无形资产已经完成并具有使用或出售的意图。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.08492910254652195,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.08492910254652195,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "3.无形资产出售时，应当能够证明用该无形资产生产的产品存在市场或无形资产自身存在市场；无形资产在内部使用时，应当证明其有用性。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.44638822665342415,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.44638822665342415,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "4.有足够的资源支持来完成该无形资产的开发，并且企业有能力使用或出售该无形资产。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.047003565692089064,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.047003565692089064,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "5.无形资产开发阶段的费用支出能够可靠地计量。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.808882412491236,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6211732900700603,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "《企业会计准则——无形资产》关于企业研发费用的会计处理体现了与时俱进的思想，也体现了国家对企业研发投入的政策扶持，有利于促进企业增强自主创新能力。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5178752214867535,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "开发费用的有条件资本化增加了企业的无形资产，减轻了经营者在开发阶段的压力，避免了企业为了达到利润目标而减少研发费用的短期行为。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6698339009344224,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "客观地计量无形资产的价值，可以更便捷地获取企业的无形资产预期收益，明晰企业的财务状况，促使企业更加重视研发活动，加大研发费用的投入，提高企业研发费用的绩效。"
                        }
                      ]
                    }
                  ]
                },
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.1.3.2 研发费用的内容",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5644298641661858,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5644298641661858,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "财政部于2007年9月4日发布了《关于企业加强研发费用财务管理的若干意见》"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.611751885599777,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.611751885599777,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "（财企[2007] 194号），该意见明确了研发费用的基本内容。研发费用是指指企业在产品、技术、材料、工艺、标准的研究、开发过程中发生的各项费用，包括："
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.17883584521876023,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.17883584521876023,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "1.研发活动直接消耗的材料、燃料和动力费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.49304264206788634,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.49304264206788634,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "2.企业在职研发人员的工资、奖金、补贴、津贴、住房公积金、社会保险费等人工费用以及外聘研发人员的劳务费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.1433521118294153,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.1433521118294153,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "3.用于研发活动的仪器、设备、房屋等固定资产的折旧费或租赁费以及相关固定资产的运行维护、维修等费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.1594602783888717,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.1594602783888717,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "4.用于研发活动的软件、专利权、非专利技术等无形资产的摊销费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.06544885962430595,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.06544885962430595,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "5.用于中间试验和产品试制的模具、工艺装备开发及制造费，设备调整及检验费，样品、样机及一般测试手段购置费，试制产品的检验费等。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.12035695033478414,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.12035695033478414,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "6.研发成果的论证、评审、验收、评估以及知识产权的注册费、申请费、代理费等费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.18782374069074828,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.18782374069074828,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "7.通过外包、合作研发等方式，委托其他单位、个人或者与之合作进行研发而支"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.23203485149697595,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.23203485149697595,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "付的费用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.16628432996405343,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.16628432996405343,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "8.与研发活动直接相关的其他费用，包括技术图书资料费、会议费、资料翻译费、差旅费、外事费、办公费、研发人员培训费、专家咨询费、培养费、高新科技研发保险费用等。"
                        }
                      ]
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.1.4 企业绩效与企业绩效评价",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.2069364501403923,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.182669427447059,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "“绩效”一词来源于英文的“performance”。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.04010808730863187,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从管理学角度上讲，是组织期望的结果，是组织为实现其目标而展现在不同层面上的有效输出。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5155444605002777,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "绩效是绩与效的组合，绩就是业绩，体现企业的利润目标；效就是效率、效果、态度、品行、行为、方法、方式。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.46861447488442387,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "效是一种行为，体现的是企业的管理成熟度目标。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.5144324637391802,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5144324637391802,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "根据《韦伯斯特新世界词典》的解释，针对企业正在执行或已完成的活动，其所产生的重大成就或正在进行的活动或取得的成绩称为绩效。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.5349473592082165,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5349473592082165,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "对于企业绩效评价各方给出了不同的解释。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.45049119997214215,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.45049119997214215,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "王化成、驰国华等人认为，业绩评价就是按照企业目标设计相应的评价体系，根据特定的评级标准，采用特定的评价方法，对企业一定经营期间的经营业绩作出客观、公正和准确的综合判断[4]。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.6092473944805894,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6092473944805894,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "向显湖、彭韶兵等人认为，企业业绩评价是企业的利益相关者根据企业的经营及财务信息和相关的环境资料，运用相关评价指标，按照特定的评价标准和评价方法，在对企业及其内部单位或个人的经营效益（或效率）进行分析确认的基础上，对其经营业绩进行客观、公正的评判，并对企业未来的发展趋势进行预测，据以为各利益相关者提供决策信息支持的价值分析和评判过程[5]。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.5024963110399854,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5024963110399854,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "我国财政部统计司认为，企业绩效评价是指运用数理统计和运筹学原理，特定指标体系，对照统一的标准，按照一定的程序，通过定量定性对比分析，对企业一定经营期间的经营效益和经营者业绩做出客观、公正和准确的综合评判[6]。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.1862246779161079,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5796219192771356,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "本文结合各方面的观点，认为企业绩效是指在一定经营期间内企业为实现企业目标所取得的成果，成果是以财务指标和非财务指标来体现的盈利能力、营运能力、成长能力、偿债能力等经营成果的总称。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6066027586389722,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "本文主要以财务指标中的盈利能力和成长能力衡量企业绩效。"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "2.2 相关理论",
          "children": [
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.2.1 企业产权理论",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.02666666666666667,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.02666666666666667,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "产权是财产权利的简称， 是指财产所有权以及与财产所有权有关的财产权。产权"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.7751555190067617,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.003938148033709214,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "包括狭义的所有权、占有权、支配权、使用权。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7712173709730525,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "产权理论的内容极为丰富，其中与业绩评价最为相关的是企业产权理论。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 3.776850494927427,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7739551690504946,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "现代企业产权理论，又称企业法人制度，即企业的法人地位和法人所必须的法人财产只有作为市场经济主体的企业明确其所有权后，才能独立经营、自负盈亏，建立真正的经济关系[7]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.794627968769459,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "产权理论的核心是企业所有者与企业经营者之间的契约关系。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5832022322405623,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "现代企业的典型特征就是所有权与经营权分离以及由此带来的信息不对称。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6674719503410596,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "股东将资本投入企业，尽管他们拥有剩余索取权和控制权，但是具体的日常经营由经理人员负责。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2253204399566815,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "由于经理人员同股东之间存在利益不一致，经理人员可能通过损害股东的利益达到自己利益的最大化，为了保护自己的资本，股东需要经理人员向他们披露相关信息，报告资本的经营情况，并以此为依据进行决策。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7322727345691704,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "同时，从债权人的角度出发，他们也希望企业披露相关的信息以衡量企业偿债能力并作出相关决策。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.7242567927673471,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.8859347883047627,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "企业产权理论向我们揭示了企业信息披露的重要性。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.8208695652173914,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "现代企业，尤其是上市公司由于经营权和所有权的高度分离，企业所有者为了了解企业的经营情况要求企业披露更加详细的信息供其进行投资决策。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.01745243924519285,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "大股东可以据此做出对经营者的奖惩，小股东则会据此作出是否继续投资的决策。"
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.2.2 技术创新理论",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.7208008092552555,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2438012624558063,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "技术创新理论由美籍奥地利经济学家熊彼特在1912年出版的《经济发展理论》中首次提出[8]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.21291370210906502,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "该理论从生产活动实际出发，认为“创新”是生产要素和生产条件的新的组合，从而建立一种新的生产函数模型，创新包括使用新的生产方法、生产新的产品、拓展新的销售市场、开辟新的供应商、建立新的组织形式。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.26408584469038415,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "技术创新理论认为创新是社会发展的推动力，创新在经济发展中起着独特而重要的作用。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.6421138945197257,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2531458821754194,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "创新理论自诞生后，经过不断发展完善，形成了包括新古典经济增长理论、内生经济增长理论等多个理论。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.1969838904069583,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "新古典经济增长理论使用劳动和资本生产一种均质产品，在假定技术不变的前提下，考察资本在经济增长中所起的作用；内生经济增长理论把技术进步视为经济的内生变量和知识的累积的结果，认为知识积累才是经济增长的原动力。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.19198412193734798,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "伴随着人类历史的发展，人们认识的不断深入，促使创新理论不断完善，同时，创新理论的发展更好的指导了生产实践活动，从而促进了人类社会的发展。"
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.2.3 投入产出理论",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.289344833963187,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.4321115479437098,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "投入产出分析（Input-Output Analysis）是指研究经济系统各个组成部分间表现为投入与产出的相互依存关系的数量经济分析方法[9]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5503294236277184,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "“经济系统”，可以是整个国民经济，也可以是地区、部门或企业，也可以是多个地区、多个部门、多个国家。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3069038623917589,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "“部分”，指所研究的经济系统的组成部分。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.2971941185869089,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.012187813284973663,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "各种产品和服务。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2669808227913918,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "“投入”，是指各个部门或产品在其生产或者运营过程中所必须的物质或劳务投入。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.01802548251054347,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "“产出”，是指各个部门或产品的产出量的分配与使用。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.0455077948168277,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.15958612118472862,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "投入产出理论，是由俄罗斯裔美国经济学家、哈佛大学教授瓦西里・列昂惕夫(Wassily Leontief 1905-1999)创立的。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.39051905733028286,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "投入产出分析的理论基础是一般均衡理论。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.4954026163018162,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "它的特点是，在研究系统内外错综复杂的相关关系时，通过建立相应的模型，考察模型内任一部分最初数据的改变对经济系统整体各个部分带来的改变及影响，帮助使用者找到分析问题、解决问题的方法。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.2416119505477768,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2416119505477768,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "这理论自从诞生以来，受到经济界和各国政府的广泛关注，广泛应用于一个国家的经济结构的分析，宏观层面上国家、地区的经济情况、资源环境情况分析，人口教育投入产出分析，从而建立起整个社会生产、分配、消费各环节的平衡，以及社会产品在物质形态、价值形态方面的平衡。"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": true,
          "part": [
            "研究综述"
          ],
          "chosen": false,
          "text_content": "2.3 国外文献综述",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 1.211871496320461,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3477630532866338,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "国外对研发投入问题的研究较早，不论是理论上还是实务上都取得了丰硕的研究成果。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8641084430338273,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研发投入影响因素研究、研发投入与企业绩效关系研究仍是国外从企业层面研究研发投入的热点。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.434277248370632,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.18363380970642967,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "国外对研发投入的影响因素研究主要集中在公司规模、资本结构、公司治理以及市场规模等方面。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5482283851902819,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Schumpeter（1950）首先对企业规模与R&amp; D关系进行了研究，他认为足够大的企业规模所具有的资源禀赋是创新的基本条件[10]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2170816204799398,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "由于研发是一项长期的投资活动，需要长期的财务支持，规模大的公司在研发投入资金提供方面具有更大的优势。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.4853334329939806,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Soete (1979)用R&amp; D费用来衡量R&amp; D活动的投入，采用美国《商业周刊》收集的美国1975-1976年间700家大公司的R&amp; D支出数据，分析发现R&amp; D投入随着企业规模的扩大而增大[11]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.17224539300100122,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.07977320199748741,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "[12]. Bhagat and Welch（1995）指出美国公司研发与上一年资产负债率呈显著正相关[13]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.09247219100351381,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Nam, Ottoo和Thornton（2003）认为高负债的公司会倾向于低水平的研发投资[14]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.8098634139040175,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8098634139040175,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "国外对研发投入与企业绩效关系研究，大多肯定了研发投入与企业绩效的正相关"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.9941737819026804,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.024559189682073622,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "关系。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6244370328282032,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Griliches（1986）的研究结果表明研发支出对美国企业生产力和绩效的提高有着显著的贡献[15]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.71366933279543,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Deng，Lev and Narin(1999), S. David young and Stephen F.0 Byren（2000）实证研究了企业研发支出与未来成长价值的关系，发现企业研发投入对未来成长机会存在显著的正影响。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6315082265969735,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Zhen Deng（2002）以申请和授让专利数量来衡最企业对研发活动的投入，选取股票报酬衡量企业业绩，进行多元回归分析，得出美国企业专利数量、研发密度与股票的绩效呈显著正相关的结论。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 2.341748089796664,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8195227665905496,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "搜集美国相关企业1975-1996年期间的数据作为研究对象，研究研发投入与企业绩效的关系，研究发现企业的研发投入与其营运收入、销售增长及净利润等被解释变量之间存在正相关关系。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6448557291117261,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Han和Manry（2004）以韩国企业为研究样本，通过实证研究发现，研发支出额对企业有正向的积极影响。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5798028571594317,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研发支出资本化金额与企业绩效的相关性程度比研发支出费用化金额与企业绩效的相关性更强。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2975667369349565,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Catherine（2006）对高科技公司的研发投入回报效率进行了分析，结果表明：研发投入具有相应的回报率，且同样的高科技产品，在不同的生命周期，高科技公司的研发投入回报率是不同的[16]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.356722474585661,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3807276162433443,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "国外对研发投入之后滞后性研究也不断开展。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7235006394166726,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Lev、Stlgiannis(l996)，搜集大量研发密度较高的企业数据，分行业实证研究每年的研发支出与第二年经营收入的关系，结果表明，研发投入对企业的经营绩效有明显的滞后性，并且滞后胜的影响时间依行业的不同而存在差异[17]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2524942189256441,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Valdemar smith, Mogens Dilling-Hansen等（2004）选取丹麦1995-1997年制造业公司数据，运用修正的Cobb-Douglas生产函数模型，实证研究研发经费对绩效影响的滞后性，结果表明：研发经费支出的短期效应很不显著，这一期间研发经费支出的收益率大约在9%-12%[18]。"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "2.4 国内文献综述",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 1.36168205032327,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7521710015156613,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "我国关于研发投入与企业绩效关系的实证研究起步较晚，研发投入影响要素研究、研发投入与企业绩效相关性研究是目前国内的研究热点。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6095110488076088,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "然而，有关企业研发投入与经营绩效相关性的研究结果还存在明显的差异，部分学者得出研发投入与企业绩效正相关的结论，部分学者得出研发投入与企业绩效不相关。"
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.4.1 研发投入影响因素相关研究",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 2.6893164265415237,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5291692227404778,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "柴俊武、万迪昉（2003）则发现企业规模与企业R&amp; D投入强度呈倒U型曲线，当企业规模较小时，与企业R&amp; D投入强度正相关；当企业规模较大时，与企业R&amp; D投入强度负相关[19]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5456144104579705,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "安同良、施浩、Ludovico Alcorta（2006）研究发现：行业是影响企业研发活动的最主要因素之一, 在研发的强度、频率、主体及研发的分配与方向方面，都表现出明显的行业间差异。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3372721048069927,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "他们认为，行业的差异意味着技术特征和市场特征上的差异，由于产业间劳动力、资本、技术与知识等要素禀赋的不同以及产业演化的时空动态差别使企业研发行为呈现出内生化的行业差异。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5255869156655703,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "同时，研究发现：与小企业相比，大企业更多地会进行持续性研发活动，更倾向于设立独立的研发部门，研发支出经费也逐渐向试验发展倾斜。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.05242400336151096,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "同时，中国小公司、中型公司、大公司R&amp; D强度的趋势存在着明显的倾斜的V型结构关系[20]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6992497695090012,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "刘笑霞，李明辉（2009）利用我国制造企业2005年的调查数据，研究企业研发支出及研发强度的影响因素。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 2.98909063577651,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5129564602463328,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "发强度之间存在显著正向相关关系，但企业规模与研发支出之间仅呈不显著的正向相关关系[21]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6605068390333838,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "吕媛，黄国良（2009）收集了2004-2006年我国上市高新技术企业对外披露的年报中研发费用数据并进行实证研究，研究发现研发投入与净营运资金、资产负债率、净利润、产权比率正相关，与企业规模负相关[22]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7847563795502621,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "唐晓华，赵丰义（2011）利用我国装备制造业1996-2007年间的分行业数据，用Pool数据模型对于企业自主研发投入的影响因素进行实证研究，研究结果表明，政府研发投入、企业规模、公司治理水平对企业自主研发投入具有显著的促进作用[23]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6302124172407797,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "陈海生、卢丹（2011）选取非国有控股上市公司及国有控股上市公司数据进行对比研究，研究发现国有控股上市公司研发强度明显低于国有控股公司，高负债水平对研发强度存在显著的负向影响，发展能力和企业规模与研发强度显著负相关；每股现金流量与国有控股上市公司的研发强度不相关，但对非国有控股上市公司的研发强度有显著的正向影响[24]。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.4006585397057515,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "靳洁（2011）从生物医药类上市公司R&amp;D投资情况与披露情况两方面现状进行分析；再次，运用多元线性回归方法，构建回归模型，运用SPSS软件进行分析，最终得出五个影响生物医药类上市公司R&amp;D最显著的影响因素，即股权制衡度、企业规模、主营业务收入增长率、资产负债率以及人力资源指数[25]。"
                    }
                  ]
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "2.4.2 研发投入与企业绩效关系相关研究",
              "children": [
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.4.2.1 研发投入与企业绩效正相关",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.8182100374205995,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.8182100374205995,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "程宏伟、张永海、常勇（2006）选取96家上市企业作为研究对象，收集其对外披露的研发投入数据及企业绩效数据进行了相关性研究，研究发现，我国上市企业研发数据披露不充分，企业整体研发水平低，研发投入与企业绩效正相关，研发投入对企业绩效的影响逐年降低[26]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5342082337195619,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.31578982090021007,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "王玉春、郭媛嫣（2008）以制造业和信息技术业A股上市公司作为研究对象，利用上市公司公开发布的财务数据和有关信息，采用实证分析方法，对上市公司研发投入与产出效果之间的相关性进行分析。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.21841841281935184,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "分析表明，上市公司研发资金投入与盈利能力呈正相关关系，与成长能力具有相关性[27]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.16627402075495554,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.16627402075495554,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "孔庆景（2010）选用2007年至2008年期间2年内有完整的研发费用，营业收入，"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.716161691607952,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5747601606744484,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "销售额，资产和市场价值记录的126个上市公司为样本，采用研发强度和公司业绩的变量来验证研发投入与企业业绩相关性。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.1414015309335036,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "结果发现，研发投资对公司业绩的影响整体上是积极正相关的[28]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.21719778180416888,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.21719778180416888,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "白沈琼（2010）选取我国生物医药行业上市公司代表为研究对象，利用06年至"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7338022434511708,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7338022434511708,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "08年间R&amp;D投入数据以及相关的财务指标，同时采用绝对数和相对数两组数据对我国生物医药企业R&amp;D投入与绩效之间相关性进行分析，研究结果表明：总体上我国"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6848846496543037,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6848846496543037,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "生物医药企业R&amp;D投入与企业绩效之间存在明显的正相关关系，生物医药企业R&amp;D"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5767712490089016,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5767712490089016,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "经费投入的增加促进了企业盈利能力和发展能力的增强[29]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.8166666666666667,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.8166666666666667,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "柴小康（2012）利用医药和生物制品行业上市公司2007-2010年的研发数据对企业研发投入和企业业绩的相关性进行了检验，结果表明：研发投入与企业业绩呈显著正相关关系，这种关系具有滞后性且对滞后两期和三期的企业业绩影响更为显著[30]。周江燕（2012）以制造业71家上市公司为研究对象，通过对样本公司R&amp; D 投"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.3681702685213293,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5385245295897927,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "入与企业业绩及企业价值的相关性分析。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.34197382422063305,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "研究结果表明，我国制造业上市公司的R&amp;D投入强度偏低，R&amp;D投入明显不足，但R&amp;D投入强度在2007-2009年3年中逐年上升。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.48767191471090343,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "企业当期R&amp; D投入与企业当期营业毛利率有显著的正相关关系，滞后一期R&amp;D投入与当期营业毛利率仍然存在较显著的正相关关系[31]。"
                        }
                      ]
                    }
                  ]
                },
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.4.2.2 研发投入与企业绩效不相关或相关性不显著",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6474942862438167,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6474942862438167,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "朱卫平、伦蕊（2004）选取197家高新技术企业为数据样本，实证研究发现我国高新技术企业的科技资金、人力资源投入与企业绩效之间不存在显著的相关关系[32]。李映照和潘听（2005）选取深沪两市17家电子行业的上市公司和10家医药行业"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6371931949752306,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6371931949752306,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "的上市公司为样本，通过实证研究企业R&amp;D支出与企业绩效之间存在正相关关系，但相关关系不明显。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7513837644466579,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7513837644466579,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "王君彩、王淑芳（2008）选取电子信息企业作为研究对象，研究研发投入与企业业绩的关系，研究发现企业研发投入与企业业绩之间的相关关系不显著[33]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6921893543600078,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6921893543600078,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "邱冬阳（2002）选取对外披露研发数据的上市公司作为样本，采用实证研究方法，分析企业R&amp;D支出与企业业绩的相关性，研究发现上市公司R&amp;D支出与企业业绩之间不存在显著的相关关系[34]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7418853634546515,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7418853634546515,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "梅雪和韩之俊（2006）选取高新技术企业作为研究对象，通过收集企业研发投入、净资产收益率等指标，研究研发投入与企业业绩的关系，研究未发现企业净资产收益率与研发投入之间存在相关性。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7845868669520748,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7845868669520748,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "游春（2010）选取中小企业作为研究对象，使用面板数据实证研究研发投入与企业绩效之间的关系，研究发现，研发投入强度与净资产收益率、主营业务增长率均没有显著的相关关系，即研发投入与企业绩效不存在显著的相关关系[35]。"
                        }
                      ]
                    }
                  ]
                },
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2.4.2.3 研发投入滞后性相关研究",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.829218093134358,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.829218093134358,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "严欣健（2012）选用102家创业板企业作为研究样本，实证研究研发投入与企业绩效之间的关系，研究发现研发投入与企业绩效正相关，且研发投入效果具有滞后性，滞后2年相关性最显著[36]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.47218113249631666,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.47218113249631666,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "赵心刚，汪克夷，孙海洋（2012）选用2007-2011年我国制造业上市企业作为研"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.2097811322125471,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7203294967338378,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "究对象，采用双向固定效应模型实证分析了上市企业研发投入对企业绩效的滞后效应。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.4894516354787092,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "研究发现，我国上市公司的研发投入对公司绩效存在显著的滞后效应，且滞后两年的效果最为显著[37]。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.843035320260154,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.843035320260154,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "高丽丽（2012）选用2007-2010年上市信息技术企业作为研究对象，实证研究研发投入与企业绩效的关系，研究发现研发投入对企业盈利能力的影响具有滞后性，且滞后两年的影响显著[38]。"
                        }
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "研究综述"
      ],
      "chosen": false,
      "text_content": "2.3 国外文献综述",
      "children": [
        {
          "type": 1,
          "outLvl": "",
          "score": 1.211871496320461,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.3477630532866338,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "国外对研发投入问题的研究较早，不论是理论上还是实务上都取得了丰硕的研究成果。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.8641084430338273,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "研发投入影响因素研究、研发投入与企业绩效关系研究仍是国外从企业层面研究研发投入的热点。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 1.434277248370632,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.18363380970642967,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "国外对研发投入的影响因素研究主要集中在公司规模、资本结构、公司治理以及市场规模等方面。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.5482283851902819,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Schumpeter（1950）首先对企业规模与R&amp; D关系进行了研究，他认为足够大的企业规模所具有的资源禀赋是创新的基本条件[10]。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.2170816204799398,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "由于研发是一项长期的投资活动，需要长期的财务支持，规模大的公司在研发投入资金提供方面具有更大的优势。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.4853334329939806,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Soete (1979)用R&amp; D费用来衡量R&amp; D活动的投入，采用美国《商业周刊》收集的美国1975-1976年间700家大公司的R&amp; D支出数据，分析发现R&amp; D投入随着企业规模的扩大而增大[11]。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.17224539300100122,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.07977320199748741,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "[12]. Bhagat and Welch（1995）指出美国公司研发与上一年资产负债率呈显著正相关[13]。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.09247219100351381,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Nam, Ottoo和Thornton（2003）认为高负债的公司会倾向于低水平的研发投资[14]。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.8098634139040175,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.8098634139040175,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "国外对研发投入与企业绩效关系研究，大多肯定了研发投入与企业绩效的正相关"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 1.9941737819026804,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.024559189682073622,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "关系。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6244370328282032,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Griliches（1986）的研究结果表明研发支出对美国企业生产力和绩效的提高有着显著的贡献[15]。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.71366933279543,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Deng，Lev and Narin(1999), S. David young and Stephen F.0 Byren（2000）实证研究了企业研发支出与未来成长价值的关系，发现企业研发投入对未来成长机会存在显著的正影响。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6315082265969735,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Zhen Deng（2002）以申请和授让专利数量来衡最企业对研发活动的投入，选取股票报酬衡量企业业绩，进行多元回归分析，得出美国企业专利数量、研发密度与股票的绩效呈显著正相关的结论。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 2.341748089796664,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.8195227665905496,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "搜集美国相关企业1975-1996年期间的数据作为研究对象，研究研发投入与企业绩效的关系，研究发现企业的研发投入与其营运收入、销售增长及净利润等被解释变量之间存在正相关关系。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6448557291117261,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Han和Manry（2004）以韩国企业为研究样本，通过实证研究发现，研发支出额对企业有正向的积极影响。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.5798028571594317,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "研发支出资本化金额与企业绩效的相关性程度比研发支出费用化金额与企业绩效的相关性更强。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.2975667369349565,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Catherine（2006）对高科技公司的研发投入回报效率进行了分析，结果表明：研发投入具有相应的回报率，且同样的高科技产品，在不同的生命周期，高科技公司的研发投入回报率是不同的[16]。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 1.356722474585661,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.3807276162433443,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "国外对研发投入之后滞后性研究也不断开展。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7235006394166726,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Lev、Stlgiannis(l996)，搜集大量研发密度较高的企业数据，分行业实证研究每年的研发支出与第二年经营收入的关系，结果表明，研发投入对企业的经营绩效有明显的滞后性，并且滞后胜的影响时间依行业的不同而存在差异[17]。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.2524942189256441,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Valdemar smith, Mogens Dilling-Hansen等（2004）选取丹麦1995-1997年制造业公司数据，运用修正的Cobb-Douglas生产函数模型，实证研究研发经费对绩效影响的滞后性，结果表明：研发经费支出的短期效应很不显著，这一期间研发经费支出的收益率大约在9%-12%[18]。"
            }
          ]
        }
      ]
    }
  ],
  "研究假设": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "研究假设"
      ],
      "chosen": false,
      "text_content": "3.1 研究假设",
      "children": [
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": true,
          "part": [
            "研究假设"
          ],
          "chosen": false,
          "text_content": "3.1.1 研发投入与盈利能力",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.602682362731695,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.602682362731695,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "伴随着知识经济的蓬勃发展，在整个经济运行过程中，智力资源重要性越来越突出，企业产品的技术含量也不断提升，对医药制造企业来说，加大新产品研发投入，是医药制造企业保持核心竞争力的源泉和持续发展的动力，只有不断通过研发与创新才能在市场竞争中立于不败之地。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6000545745768792,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6000545745768792,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "在提高企业的竞争力方面，研发投入的作用体现在以下几点："
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.1567939243990417,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.26220459873476787,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "第一，研发投入可以提高生产效率，降低生产成本。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3744708620764588,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "在激烈的市场竞争环境下，降低生产成本已成为企业获得生存与发展的重要手段。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5201184635878151,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "一方面，研发投入给企业带来的新的生产技术与方法能大大提高产品的生产效率，降低产品生产中所需的原材料、燃料、人工费等支出，从而实现降低生产成本的目的；另一方面，研发投入可以给企业带来规模经济，实现生产要素集中化，获取最佳经济效益。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.6082419737107656,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6900069087636249,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "第二，研发投入可以给企业带来差异优势。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.36604336506925217,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "差异化战略是指企业产品、服务与竞争对手有显著的差别，以获得竞争优势。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5521916998778884,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "企业研发投入所研发的新产品在外观、性能、质量等方面与竞争对手产品存在很大不同，因而能为企业带来差异化优势，获取高于竞争对手的利润。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.8812146761922992,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.34251142787408395,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "第三，研发投入可以降低学习曲线。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.05909896935298966,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "学习曲线(Learning curve)是表示单位产品生产时间与所生产的产品总数量之间的关系的一条曲线，随着产品累计产量的增加，单位产品的成本会以一定的比例下降。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.47960427896522556,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "在生产技术上的研发投入，能快速改善企业生产效率，缩短生产时间，使企业在生产同等数量的产品时耗费更少的费用，从而降低产品成本。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.06202650920162,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5323791752433158,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "最后，研发投入可以帮助企业及时根据市场需求变化进行生产调整，从而争取更多地消费者，占领产品市场。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5296473339583041,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "这就需要企业能预见未来的市场需求，率先进行研发投入，使自身产品时刻保持与消费者需求高度统一[39]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5565069739995078,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5565069739995078,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综上，基于以上的理论分析，我们认为研发投入可以提高企业的经营业绩。因而，本文提出以下假设："
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "4",
              "score": 0.0,
              "selected": true,
              "part": [
                "研究假设"
              ],
              "chosen": false,
              "text_content": "假设1：医药制造企业的研发投入与其盈利能力指标正相关",
              "children": []
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6160772434659123,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6160772434659123,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "假设1.1医药制造企业R&amp;D 费用投入、技术人员投入与企业营业利润正相关假设1.2医药制造企业R&amp;D投入强度、技术人员投入强度与企业营业利润率正"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.15930026645464343,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.15930026645464343,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "相关"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "3.1.2 研发投入与成长能力",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 1.0224422219789142,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.44717744766509965,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "企业的成长能力是管理者、投资者等利益相关者共同关心的话题，也是企业未来价值所在。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5752647743138145,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "国内外学者对创新与企业成长之间的关系进行了大量的研究，逐渐形成了一些具有价值的理论和研究成果。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.477349582887758,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.40240577908279057,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "熊彼特（1912）认为创新是企业成长的推动力，创新是生产要素与生产条件的新组合，能为企业带来超过行业平均水平的利润。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.07494380380496743,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Solvay和Sanglier等（1998）设计了一个公司成长模型，认为公司成长取决于长期技术进步趋势和由于商业周期变化而导致的短期需求波动2个因素[40]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 2.918462705095485,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7157071114625451,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "F.0 Byren（2000）实证研究了企业研发支出与未来成长价值的关系，发现企业研发投入对未来成长机会存在显著的正影响。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.693564615416894,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "肖惠（2008）选取2005-2007年高新技术企业作为研究样本，选用营业收入增长率作为企业成长性指标，实证研究发现短期内企业研发投入与企业成长性负相关，但不显著[41]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7690059018826212,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "张慧丽（2010）选取2005-2008年中小板上市公司作为样本，采用实证研究方法研究研发投入与企业成长性之间的关系，研究发现研发投入与企业的规模扩张能力正相关[42]。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7401850763334249,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "尹文兰（2012）选取2008-2010年上市医药公司作为研究样本，实证研究发现企业研发投入与企业成长性显著正相关，并且企业研发投入对企业成长性具有滞后性[43]。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6395694438099838,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6395694438099838,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综上，基于熊彼特的技术创新理论和前人的研究成果的，我们认为研发投入为企业带来的技术创新，能够促进企业的成长，即研发投入与企业成长能力正相关。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.11959205078909925,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11959205078909925,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "因而，本文提出以下假设："
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "4",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "假设2：医药制造企业的研发投入与其成长能力指标正相关",
              "children": []
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6324477722989399,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6324477722989399,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "假设2.1医药制造企业R&amp; D费用投入、技术人员投入与企业营业收入增长额正相关"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6096609755287647,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6096609755287647,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "假设2.2医药制造企业R&amp;D投入强度、技术人员投入强度与企业营业收入增长率正相关"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "3.1.3 研发投入滞后性",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.4247718725585846,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.14140459113733234,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研发活动结束后可能无法立即生产出技术产品并产生经济效益，这中间存在着一个滞后期。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2833672814212523,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "越来越多的国内外学者对研发投入产出滞后性进行了研究，形成了一些具有价值的研究成果。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7919407409350723,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7919407409350723,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "何玮（2003）选用1990-2000大中型工业企业作为研究对象，利用Cobb-Douglas生产函数实证分析研发投入对企业产出的影响，研究表明：企业的研发投入效果大多存在滞后性，并且研发投入效果的滞后期为二到三年[44]。赵心刚，汪克夷，孙海洋（2012）选用2007-2011年我国制造业上市公司作为研究对象，采用双向固定效应模型实证分"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 3.09073988823136,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7444551165790825,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "析了研发投入对企业业绩的滞后效应。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.731786058906793,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研究表明，我国上市公司的研发投入对企业业绩存在显著的滞后效应，且滞后两年的效果最为显著。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7673329656628218,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "柴小康（2012）利用医药和生物制品行业上市公司2007-2010年的研发数据对企业研发投入和企业业绩的相关性进行了检验，结果表明：研发投入与企业业绩呈显著正相关关系，这种关系具有滞后性且对滞后两期和三期的企业业绩影响更为显著。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8471657470826627,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "高丽丽（2012）选用2007-2010年上市信息技术企业作为研究对象，实证研究研发投入与企业绩效的关系，研究发现研发投入对企业盈利能力的影响具有滞后性，且滞后两年的影响显著。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5752213413406848,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5752213413406848,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综上，基于前人的研究成果，我们认为企业研发投入效果有滞后性。因而，我们提出以下假设："
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "4",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "假设3：企业研发投入对企业业绩影响存在滞后性",
              "children": []
            }
          ]
        }
      ]
    }
  ],
  "数据与样本": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "数据与样本"
      ],
      "chosen": false,
      "text_content": "3.2 样本选取与数据收集",
      "children": [
        {
          "type": 1,
          "outLvl": "",
          "score": 1.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 1.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本文选取2010年至2012年沪深两市上市医药制造企业作为研究对象，并根据研究需要对样本企业进行了取舍。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.7827319434506679,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7827319434506679,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "根据研究需要，本文所选样本企业的筛选标准如下："
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.12826487432941935,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.12826487432941935,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（1）按照中国证监会公布了《上市公司行业分类指引（2012年修订）》划分的行业中，我们选取制造业大类中医药制造业上市公司。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.7020520558944103,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7020520558944103,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（2）研究期间所需的财务数据披露必须连续，任一一年所需的研究数据披露有缺失的企业，该样本予以剔除；"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.6322386891327472,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6322386891327472,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（3）研究期间任一一年的营业收入小于或者等于零的企业，该样本予以剔除；"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.6280329493539578,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6280329493539578,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（4）研究期间任一一年的营业利润小于或者等于零的企业，该样本予以剔除；"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.6263420529369835,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6263420529369835,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（5）研究期间任一一年的所有者权益小于或者等于零的企业，该样本予以剔除；"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.6743986175480516,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6743986175480516,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "（6）研究期间有任一一年企业出现ST，该样本予以剔除。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.5881965624581011,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.5881965624581011,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "按照以上6条标准进行数据收集，最终确定符合本文研究条件的上市医药制造企"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.6943333680752358,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "业共46家。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6943333680752358,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本文收集的数据包括企业研发费用支出、技术人员数、在职员工总数、营业收入、营业利润、营业收入增长率、资产总额、资产负债率等。"
            }
          ]
        },
        {
          "type": 1,
          "outLvl": "",
          "score": 0.7879295162402999,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6720146404433875,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本文所使用的数据主要来源于巨潮资讯网（http: //www. cninfo. com. cn）和新浪财经网（http: //finance. sina. com. cn）披露的企业年报，以及北京聚源锐思数据科技有限公司开发的RESSET金融研究数据库。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.11591487579691241,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本文数据分析采用EXCEL和SPSS16.0软件处理。"
            }
          ]
        }
      ]
    }
  ],
  "变量定义": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "变量定义"
      ],
      "chosen": false,
      "text_content": "3.3 变量选取",
      "children": [
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": true,
          "part": [
            "变量定义"
          ],
          "chosen": false,
          "text_content": "3.3.1 解释变量",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 2.1185105204246275,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6945200176741928,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综合前人对研发投入的相关研究，医药制造企业的研发投入不仅体现在研发费用支出上，还体现在科技人员投入上。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6958329077359426,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "很多学者在研究研发投入与绩效关系时多选用研发投入相对数即研发投入强度作为解释变量，研发投入强度即企业研发投入与营业收入的比值。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7281575950144921,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "选用该变量可有效规避企业规模不同为本文研究带来的差异影响，但是，本文为了保证分析的完整性和说服力，决定采用相对指标和绝对指标两种类型的数据进行对比分析，从而论证研发投入与企业绩效的关系。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 4.031075420485418,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5444774443675673,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "目前，我国会计制度与会计准则对企业研发投入信息地披露并非强制性，各上市公司主要利用两种方式对企业研发投入对外披露，一是在资产负债表正表中进行披露，二是在报表附注中披露。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.32285598305631447,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "资产负债表正表中列示的“开发支出”项目，它反映企业开发无形资产过程中能够资本化形成无形资产成本的支出部分。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11031058391408027,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "按照现行会计准则规定除开发阶段符合资本化的研发费用予以资本化，计入开发支出项目外，其他研发费用应费用化，计入当期损益。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.44995391648462724,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "有些上市企业未严格按照会计准则要求，而是将全部研发费用进行资本化处理，计入“开发支出”项目，而有些企业严格按照会计准则要求，将研发费用分开处理。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.47683847029182924,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "这样就为企业研发数据的收集造成一定的困扰。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.09195892404521727,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "另外，报表附注中披露与研发支出有关的科目种类繁多，包括“管理费用”、“专项应付款”、“支付的其他与经营活动有关的现金”、“在建工程”、“长期应付款”等。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3154068505312989,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "披露的研发投入名称也不规范，其科目有：“研究与开发”、“技术开发费”、“研发费”、“研发支出”、“研究开发费”、“技术研究费”、“新产品研制费”、“研究试验费”等。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.17882445975171363,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "披露方式的多样化，披露内容的不统一，给获取统一口径的研发投入数据增加了困难。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5561472274276447,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "本文为统一数据口径，确保数据真实可靠，手工收集医药制造企业对外披露的财务报告中研发支出所列金额作为企业研发投入数据。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.4045689857321977,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "另外，由于企业在对外报告中，大多仅公布了技术人员数量而未公布研发人员数量，所以本文选用技术人员数量代替研发人员数量。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5797325748829267,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "对于同时公布技术人员及研发人员的企业本文采用两者之和作为研究数据。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.3892785252623451,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3892785252623451,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "根据研究需要，选取研发投入费用、研发投入强度、技术人员数量和技术人员投入强度作为本文解释变量。"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "3.3.2 被解释变量",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.592284938084408,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.592284938084408,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "本文在借鉴前人相关研究的基础上，结合本文的研究目的，在综合考虑数据获取难易基础上，选取医药制造企业的盈利能力和成长能力予以研究，选用营业利润率作为企业盈利能力的评价指标，营业收入增长率作为企业成长能力评价指标。两个指标"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.001360515394924836,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.001360515394924836,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "的计算公式如下："
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.12848978987577558,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.12848978987577558,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "营业利润率=营业利润/营业收入"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.10573704692631067,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.10573704692631067,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "营业收入增长率=本期营业收入增加额/上期营业收入"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "3.3.3 控制变量",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.4754476744511802,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.19545626538614602,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "研发投入的影响因素有很多，包括公司规模、资本结构、所处行业、股权结构、公司性质等。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.27999140906503417,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "综合考虑前人研究的基础上，本文选取公司规模、资产负债率作为控制变量。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.329896929381268,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.021806154134676264,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "（l）公司规模（S）。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5559291597775531,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "公司规模会对企业绩效产生影响，公司规模不同，企业自有的可用研发资金也不同，因而研发活动在一定程度上会受到企业规模的限制。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6549063879376517,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "同时，公司规模不同也可能会导致国家对企业扶持力度不同，企业收到的研发资金支持可能会不同，因此引入企业规模作为控制变量，可以使企业研发投入绩效研究更具实用性。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.09725522753138702,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "本文选用期末资产总额的自然对数衡量公司规模的大小。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.025423157897377664,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.025423157897377664,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "公司规模（S）=Ln（资产总额）"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5091333081173853,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0009012553929149436,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "（2）资产负债率(LR)。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5082320527244704,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "资产负债率是衡量企业偿债能力的指标，企业应保留合理的货币资金数量，支持研发活动，促进企业持续发展，因此引入资产负债率作为本文的控制变量。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.004856825849855275,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.004856825849855275,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "资产负债率(ALT) =负债总额/资产总额"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.20009327543184072,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.20009327543184072,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表3.1  变量选取"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['变量类型', '', '选取指标', '数据来源及计算方法'], ['解释变量', '', '研发费用投入 RD', '企业年报'], ['', '', '研发投入强度 RDI', '研发投入／营业收入'], ['', '', '技术人员 TP', '企业年报'], ['', '', '技术人员投入强度 TPI', '技术人员／企业员工总数'], ['控制变量', '', '公司规模 S', '总资产的自然对数'], ['', '', '资产负债率 ALT', '负债总额／总资产'], ['被解释变量', '盈利能力', '营业利润', 'RESSET 金融研究数据库'], ['', '', '营业利润率', '营业利润／营业收入'], ['', '成长能力', '营业收入增长率', '本期营业收入增加额／上期营业收入']]"
            }
          ]
        }
      ]
    }
  ],
  "检验": [],
  "结论与分析": [],
  "实证研究类v3": [
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "实证研究类v3"
      ],
      "chosen": false,
      "text_content": "3.4 模型构建",
      "children": [
        {
          "type": 1,
          "outLvl": "",
          "score": 1.806517276040835,
          "selected": false,
          "part": [],
          "chosen": false,
          "children": [
            {
              "type": 2,
              "outLvl": "",
              "score": 0.7318063416298088,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "本文选取研发投入的绝对数和相对数来对研发投入与企业绩效的关系进行研究，线性回归方程对绝对量和相对量指标都可以使用，柯布-道格拉斯(Cobb- Douglas)生产函数则通常作为衡量绝对量上的投入产出模型。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.6739921907308476,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "Griliches（1986）采用Cobb-Douglas生产函数模型检验了1957年到1977年美国1000家企业研发投入对生产力的影响，郭媛嫣（2008）采用Cobb-Douglas生产函数模型分析了我国制造业和信息技术业上市公司研发投入与企业绩效的关系。"
            },
            {
              "type": 2,
              "outLvl": "",
              "score": 0.40071874368017874,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "在前人研究基础上，本文构建线性回归模型和修正的柯布-道格拉斯(Cobb- Douglas)生产函数模型分析研发投入对绩效的影响。"
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": true,
          "part": [
            "实证研究类v3"
          ],
          "chosen": false,
          "text_content": "3.4.1 多元线性回归模型",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.80120197073532,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.80120197073532,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "（1）假设1、2 医药制造企业的研发投入与绩效正相关"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Y i =α 0 +α 1 RDI i +α 2 TPI i +α 3 S i +α 4 ALT i +ε  (1)"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5049014748047171,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5049014748047171,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "其中，Y i是产出变量，表示企业第i 年的绩效（盈利能力与成长能力），本文以"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.15321471247249438,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11114367719510695,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "营业利润率、营业收入增长率来衡量。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.042071035277387425,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "i表示年份，ε是为了消除其他因索影响而引入的随机变量。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7533616943230222,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7533616943230222,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "（2）假设3医药制造企业研发投入对绩效的影响具有滞后性医药制造企业第i年绩效与第i-j年的研发投入正相关："
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.00011413183525204587,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.00011413183525204587,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Y i =α0 +α1 RDI ij +α2 TPI ij +α3 S i +α4 ALT i +ε公式（2）"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.06480803083470536,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.06480803083470536,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "其中，Y表示产出变量，i表示年份(i=3)，j表示滞后期间(j=l, 2)，ε是为了消除其因素影响而引入的随机变量。"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "3.4.2 修正的柯布-道格拉斯(Cobb-Douglas)生产函数模型",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5707878854549965,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11752289067425863,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "生产函数（production function）是指在一定时期内，在技术水平不变的情况下，生产中所使用的各种生产要素的数量与所能生产的最大产量之间的关系。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.45326499478073784,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "柯布-道格拉斯(Cobb-Douglas)生产函数是引入技术资源这一因素后，在生产函数的一般形式上做出的改进，用来预测国家和地区的工业系统或大企业的生产和分析发展生产的途径的一种经济数学模型。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.00011413183525204587,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.00011413183525204587,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Q =αR a L b S c公式（3）"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "iiii"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.5938106449589238,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5938106449589238,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "其中，Q表示医药制造企业产出变量，用营业利润衡量；R表示研发费用投入，"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.035477890694513,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.49141007358177285,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "L表示技术人员投入，S表示企业资产总额。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5440678171127402,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "a、b、c表示企业研发费用投入、技术人员、总资产投入的产出弹性，i表示年份。"
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "type": 0,
      "outLvl": "0",
      "score": 0.0,
      "selected": false,
      "part": [
        "实证研究类v3"
      ],
      "chosen": false,
      "text_content": "第四章  研发投入与企业绩效实证分析",
      "children": [
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": true,
          "part": [
            "实证研究类v3"
          ],
          "chosen": false,
          "text_content": "4.1 描述性统计分析",
          "children": [
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": true,
              "part": [
                "实证研究类v3"
              ],
              "chosen": false,
              "text_content": "4.1.1 研发投入的描述性统计分析",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.6790241026041812,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6790241026041812,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "通过严格的筛选，符合本文研究要求的样本企业共46家。从下表4.1研发费用投"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.3224939930135596,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3224939930135596,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "入描述性统计分析中我们可以看到2010至2012年研发费用投入最小值、最大值、均值三个指标数据不断提高。2010 年研发费用投入的最大值为27200 万元，均值为"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.2189910345958932,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2189910345958932,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "3761.35万元；2012年研发费用投入的最大值为36989万元，均值为6089.29万元。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.9938889040043228,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.1849384546100398,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "3年中研发费用投入的最大值增长了9789万元，增长了35.99%；均值增长了2327.94万元，增长了61.89%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.8089504493942831,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表明我国医药制造企业研发费用投入不断提高。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.25561680384606583,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.25561680384606583,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "年的研发费用投入为96.46亿美元，第2位的辉瑞为94.13亿美元，第3位的诺华为"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.7572144460711278,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.0002498251637833238,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "90.70亿美元。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7569646209073444,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "三家公司研发投入都超过90亿美元（约合5590980万元），诚然有企业规模差距的原因，但也从一定程度上说明我国医药制造企业研发费用投入与国际大型医药企业还有很大差距，仍应提高研发投入。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.428802124622074,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6888447060008579,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "46家医药制造企业2010年研发费用投入的标准差为4632.13, 2012年研发费用投入的标准差为7331.01, 3年中研发费用投入标准差增长了2698.88，增长了58.26%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.739957418621216,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表明我国医药制造企业间研发费用投入差距不断扩大，诚然有市场环境、资产规模、资产结构等原因，但也提醒相关企业应重视科研投入，从而提高核心竞争力。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.44161923395933,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.44161923395933,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.1  研发费用投入描述性统计分析"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年份', '最小值万元）', '最大值万元）', '均值万元）', '标准差', '样本数'], ['2010', '163.37', '27200.00', '3761.35', '4632.13', '46'], ['2011', '145.75', '31287.00', '4417.44', '5354.53', '46'], ['2012', '296.48', '36989.00', '6089.29', '7331.01', '46']]"
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.7164619600594135,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7164619600594135,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从下表4.2研发投入强度描述性统计分析，可以看到，我国医药制造企业整体研发强度不高，2010年研发强度均值只有4.07%，3年中研发强度均值最高出现在2012年，也仅为4.52%。据英国贸易和工业部2005年发布的数据显示医药产业研发投入强"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.367726686933942,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6566006072235399,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "度在所有产业中最高，研发强度为15%,由此可见我国医药制造企业研发强度与国际相比还有很大差距。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7111260797104021,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "但从2010年至2012年研发投入强度均值的发展趋势上，我们可以看到它是逐渐上升的，研发强度均值由4.07%增加到4.52%，增长了0.45个百分点，表明医药制造企业研发投入强度不断提升，企业更加注重研发投入。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.4016038042983106,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.667573286263337,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从研发投入强度的标准差指标中，我们可以看到医药制造企业间研发投入强度的差距较大，2010年研发投入强度的标准差为2.84%，2012年研发投入强度的标准差已达3.31%，研发投入强度标准差相距0.47%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7340305180349735,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "数据说明医药制造企业间研发投入强度差距较大，可能的原因是国内有些医药制造企业开始摆脱仿制药物的发展模式，走上新药研发创新的新路，加大了研发投入在营业收入中的比重，而有些企业依然在走药物仿制的老路，医药研发投入强度没能提升。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.44419358704163986,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.44419358704163986,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.2  研发投入强度描述性统计分析"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '0.16%', '15.26%', '4.07%', '2.84%', '46'], ['2011', '0.28%', '12.66%', '4.12%', '2.80%', '46'], ['2012', '0.46%', '17.07%', '4.52%', '3.31%', '46']]"
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.1.2 技术人员的描述性统计分析",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.2137044657121505,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.22069331577248807,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从下表4.3技术人员描述性统计分析中我们可以看到2010至2012年技术人员数量最大值、均值两个指标数据不断提高。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.06851588149435132,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "2010年技术人员数量最大值为1667，均值为249.24; 2012年技术人员数量最大值为2326，均值为377.89.3年中技术人员数量最大值增长了659，增长了39.53%；均值增长了128.65，增长了51.62%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6368291468593998,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表明我国医药制造企业技术人员数量在不断增加。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.28766612158591126,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "与同期研发投入费用的增长幅度相比则显得增速比较低，可能是因为随着我国经济的不断发展，人均工资不断提高导致。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.9776415844746259,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.48845066756139244,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "46家医药制造企业2010年技术人员数量的标准差为327.88, 2012年技术人员数量的标准差为447.81, 3年中技术人员数量标准差增长了119.93，增长了36.58%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.48919091691323346,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "2010年技术人员数量的最小值为14，最大值为1667，最大值与最小值相差1653, 2012年技术人员数量的最大值最小值相差2291，表明我国医药制造企业间技术人员数量差距很大，并且有不断扩大的趋势。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.23513593194859367,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.23513593194859367,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.3  技术人员描述性统计分析"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '14', '1667', '249.24', '327.88', '46'], ['2011', '4', '1923', '310.35', '404.08', '46'], ['2012', '35', '2326', '377.89', '447.81', '46']]"
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.3740511818254812,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6701266851054961,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从下表4.4技术人员投入强度描述性统计分析，可以看到，我国医药制造企业技术创新人员投入严重不足，2010年技术人员投入强度均值只有14.01%，3年中技术人员投入强度均值最高出现在2012年，也仅为16.66%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7039244967199851,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "数据显示，欧美日等发达国家的医药企业中R&amp;D活动人员占到企业从业人员的30%左右，而本文技术人员为包括研发人员在内的所有技术人员，且技术人员投入强度仅约为发达国家医药企业研发人员投入强度的一半，说明我国医药制造企业研发人员投入不足。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.2234495490402484,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.592030021068985,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从技术人员投入强度的标准差指标中，我们可以看到医药制造企业间技术人员投入强度差距逐渐拉大，2010年技术人员投入强度的标准差为7.26%，2012年技术人员投入强度的标准差达3年中最高为9.37%，3年来技术人员投入强度标准差逐渐加大，说明医药制造企业间技术人员投入强度逐渐加大。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6314195279712634,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "然而，3年中技术人员投入强度的最小值与最大值保持30%以上的差距，2011年及2012年两者差距甚至超过了40%，说明医药制造企业间研发人员投入强度差距还比较大，应进一步缩小这种差距，提高研发人员投入强度。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.3233426547181023,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3233426547181023,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.4  技术人员投入强度描述性统计分析"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '0.78%', '31.47%', '14.01%', '7.26%', '46'], ['2011', '0.26%', '41.44%', '15.32%', '8.77%', '46'], ['2012', '2.21%', '43.58%', '16.66%', '9.37%', '46']]"
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.1.3 分组分布特征",
              "children": [
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.1.3.1 研发投入强度的分组分布特征",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.4440819727231695,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6784095833352403,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "研发投入强度是衡量一个企业技术能力和核心竞争力的重要指标。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7656723893879293,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "相关研究表明，研发投入强度不足1%的企业，生存难以为继；达到2%的企业只能勉强维持生存；超过3%，但不足5%的企业，仅仅是可以正常运营；只有研发投入强度超过5%，企业才具有了竞争能力。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6264811809003297,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6264811809003297,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "业达到10%，有些企业甚至达到20%。据统计，2006 年美国医药企业研发投入高达"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.3255204669167122,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.3255204669167122,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "552亿美元，美国医药企业平均研发强度为25.93%；2005年日本主要医药企业平均研发投入为6亿美元，研发强度为18%；德国医药企业先灵、柏林格、拜耳每年的研究与开发经费都在11-12亿美元水平，研发强度在10%-20%之间。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6336397249696377,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6336397249696377,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "但从表4.5中我们可以看出：2010-2012年研发投入强度不足1%的企业占样本总数的一成多，比较稳定；研发投入强度不足3%的企业比例逐年下降，2010年比例为"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.2887613070764399,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5204707979775238,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "34.78%，2011年比例为32.61%，2012年比例为28.26%；研发强度超3%的企业比例逐年上升，由2010年的65.22%上升到2012年的71.74%，但研发强度超5%的企业比例基本保持稳定。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7682905090989159,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "数据说明，研发投入能维持正常运营以上水平的医药制造企业比例逐渐提高，从而说明医药制造企业研发投入逐年提高，但是依靠研发投入提高竞争力的企业比例基本稳定，说明依靠研发投入提高竞争力的做法并没有在我国医药制造企业中进一步使用。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.36726685865847897,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.36726685865847897,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "表4.5  研发投入强度分组"
                        }
                      ]
                    },
                    {
                      "type": 3,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "table_data": "[['年度', '0-1%', '1%-2%', '2%-3%', '3%-4%', '4%-5%', '5%以上'], ['2010', '10.87%', '10.87%', '13.04%', '21.74%', '13.04%', '30.43%'], ['2011', '15.22%', '4.35%', '13.04%', '19.57%', '21.74%', '26.09%'], ['2012', '13.04%', '2.17%', '13.04%', '28.26%', '15.22%', '28.26%']]"
                    }
                  ]
                },
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.1.3.1 技术人员投入强度的分组分布特征",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 2.982471650555437,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5552717960524682,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "企业中技术人员所占企业总员工的比例并不是越多越好，技术人员投入强度多大为最佳，迄今并没有统一的认识。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5386381480541514,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "2001年科技部颁发的《国家高新技术产业开发区高新技术企业认定条件和办法》第五条高新技术企业认定条件的第三款中，我们可以看出，具有大专以上学历的科技人员占企业职工总数的30％以上是企业被界定为高新技术企业的一个必备条件。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5855216885468988,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "然而，从下表4.6中，我们可以看到2010年技术人员投入强度在30%以上的企业比例仅为2.17%；2011年技术人员投入强度超30%的企业比例最高，但仅为13.04%。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6601973292195943,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "3年中技术人员投入强度超过30%的企业占样本总数的比例都很低，从严格意义上来说，多数上市医药制造企业并不符合高新技术企业的条件。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6428426886823243,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "另一方面，我们看到技术人员投入强度在20%以上的企业比例3年中在不断提高，2010年为19.57%，2011年为21.74%，2012年为226.09%，说明医药制造企业更注重技术人员的引进。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.2502182650885446,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.2502182650885446,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "表4.6  技术人员投入强度分组"
                        }
                      ]
                    },
                    {
                      "type": 3,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "table_data": "[['年度', '0-10%', '10%-20%', '20%-30%', '30%以上'], ['2010', '28.26%', '52.17%', '17.39%', '2.17%'], ['2011', '26.09%', '52.94%', '8.70%', '13.04%'], ['2012', '23.91%', '50.00%', '15.22%', '10.87%']]"
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.2 企业研发投入与企业盈利能力关系分析",
          "children": [
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.2.1 研发投入与盈利能力分组分析",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.4045383004305516,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.719696302483924,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "如下表4.7所示，我们对不同研发投入强度下企业盈利能力情况进行了分析，结果显示，在不同研发投入强度水平下，企业盈利能力表现出明显的不同。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6848419979466276,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "随着研发投入强度的不断提高，企业盈利能力呈现逐渐上升的趋势。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.3475112241305435,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "27.02%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3475112241305435,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "2011年和2012年数据也完全符合随研发投入强度提高，盈利能力逐渐上升的规律。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.7971164612755774,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7971164612755774,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.7  不同研发投入强度下企业盈利能力情况"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年度', '指标', '0-1%', '1%-3%', '3%-5%', '5%以上'], ['2010', '平均营业利润率', '12.92%', '20.79%', '23.02%', '27.02%'], ['2011', '平均营业利润率', '10.47%', '14.14%', '22.22%', '30.02%'], ['2012', '平均营业利润率', '10.16%', '11.82%', '18.67%', '28.47%']]"
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.2472204622539063,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6539521710506017,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "如下表4.8所示，我们对不同技术人员投入强度下企业盈利能力情况进行了分析，结果显示，在不同的技术人员投入强度下，企业盈利能力表现出明显的不同。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5932682912033046,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "随着技术人员投入强度的不断提高，企业盈利能力基本呈现逐渐上升的趋势。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.924381539090855,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.43108145090874034,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "30%以上时，企业平均营业利润率达到最高。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.26502518817566334,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "2011年数据也完全符合随技术人员投入强度提高，盈利能力逐渐上升的趋势。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5815741443940786,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "但2010年数据出现了异常，并不完全符合随着技术人员投入强度的不断提高，企业盈利能力逐渐上升的规律，当技术人员投入强度在30%以上时企业平均营业利润率出现下降。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6467007556123726,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "分析认为之所以出现个别数据不符合规律的现象，是因为本文收集的符合研究的样本数据较少，易受个别企业盈利能力数据的影响。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.9386881559002624,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.8211009460805868,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "从上述分析中可以发现，研发投入强度、技术人员投入强度均与企业盈利能力存在一定的相关关系，尤其是研发投入强度与企业盈利能力的正向影响明显，表明研发投入与企业盈利能力正相关。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.11758720981967569,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "接下来，我们将利用数理模型对结论进行验证。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.69232037223532,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.69232037223532,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.8  不同技术人员投入强度下企业盈利能力情况"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年度', '指标', '0-10%', '10%-20%', '20%-30%', '30%以上'], ['2010', '平均营业利润率', '20.22%', '23.04%', '26.19%', '14.64%'], ['2011', '平均营业利润率', '16.27%', '20.32%', '21.44%', '33.33%'], ['2012', '平均营业利润率', '14.17%', '19.35%', '22.86%', '25.26%']]"
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "2",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.2.2 研发投入与盈利能力数理模型分析",
              "children": [
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.2.2.1 研发投入与盈利能力线性回归分析",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7262248719154693,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7262248719154693,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "上市医药制造企业研发投入强度、技术人员投入强度与企业营业利润率之间的相关关系。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.21642272412764096,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.21642272412764096,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "Y i =α 0 +α 1 RDI i +α 2 TPI i +α 3 S i +α 4 ALT i +ε  模型(1)"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5711340080544632,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5711340080544632,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "Y i是产出变量，表示企业第i年绩效，本文选用营业利润率作为衡量指标；"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.6788845646284319,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6788845646284319,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "RDI i和TPI i是投入变量，表示企业第i年研发投入，本文选用研发投入强度和技术人员投入强度分别作为衡量指标；"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.4963943026383864,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.4963943026383864,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "S i是控制变量，表示企业第i年规模，本文选用企业资产总额的自然对数作为衡量指标。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5725506055013518,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5725506055013518,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "模型数据都来自经筛选后上市医药制造企业2010-2012 年样本数据，通过"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.007813571487785803,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.007813571487785803,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "SPSS16.0和EXCEL2003软件处理，获得的回归结果如表4.9所示："
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7345852386683012,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7345852386683012,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "表4.9  企业研发投入强度对企业营利润率的回归结果"
                        }
                      ]
                    },
                    {
                      "type": 3,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "table_data": "[['', '2010', '', '', '2011', '', '', '2012', '', ''], ['', '回归系数', 't 值', 'p 值', '回归系数', 't 值', 'p 值', '回归系数', 't 值', 'p 值'], ['研发投入强度', '1.675', '2.832', '0.007', '2.245', '3.555', '0.001', '1.411', '3.648', '0.001'], ['技术人员投入强度', '0.006', '0.003', '0.978', '0.521', '2.723', '0.009', '0.275', '1.979', '0.055'], ['资产规模', '0.068', '0.041', '0.000', '0.069', '3.410', '0.001', '0.060', '4.178', '0.000'], ['资产负债率', '-0.499', '-0.584', '0.000', '-0.388', '-3.778', '0.001', '-0.348', '-4.522', '0.000'], ['Adj R2', '0.528', '', '', '0.528', '', '', '0.633', '', ''], ['F', '13.605', '', '', '13.571', '', '', '17.665', '', '']]"
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.2145218543597345,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6647210482604906,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "相关性分析及其检验结果显示，2010-2012年研发投入强度的回归系数都为正值，并且相关系数都通过了5%的显著性检验，说明研发投入强度与企业盈利能力显著正相关；2010-2012年技术人员投入强度的回归系数都为正值，但是2010年、2012年相关系数都没有通过5%的显著性检验，说明技术人员投入强度与企业盈利能力存在正相关性，但相关性不显著。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5498008060992438,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "同时，回归结果也说明了资产规模、资产负债率与企业盈利能力有显著的相关性，资产规模与企业盈利能力正相关，资产负债率与企业盈利能力。"
                        }
                      ]
                    }
                  ]
                },
                {
                  "type": 0,
                  "outLvl": "3",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4.2.2.2 柯布—道格拉斯函数探究研发投入与盈利能力",
                  "children": [
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7195118540843857,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7195118540843857,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "上市医药制造企业研发费用投入、技术人员数量与企业营业利润之间的相关关系"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.21642272412764096,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.21642272412764096,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "Q =αR a L b S c  模型(2)"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.0,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "iiii"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.0016345093155742756,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.0016345093155742756,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "构造为线性回归方程，得到：Ln Q i = Lnα+aLn R i +bLn L i +cLnS i +ε"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.2032450356570825,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5996762668811562,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "Q表示医药制造企业研发投入产出变量，用营业利润指标衡量；R表示研发费用投入，L表示技术人员投入，S表示资产总额。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6035687687759265,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "a、b、c表示企业研发费用投入、技术人员投入、资产总额的产出弹性，i表示年份(1=1, 2, 3)。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.5725506055013518,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5725506055013518,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "模型数据都来自经筛选后上市医药制造企业2010-2012 年样本数据，通过"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.007813571487785803,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.007813571487785803,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "SPSS16.0和EXCEL2003 软件处理，获得的回归结果如表4.10所示："
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7277882785080915,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7277882785080915,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "表4.10  企业研发投入与企业营业利润的回归结果"
                        }
                      ]
                    },
                    {
                      "type": 3,
                      "outLvl": "",
                      "score": 0.0,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "table_data": "[['', '2010', '', '', '2011', '', '', '2012', '', ''], ['', '回归系数', 't 值', 'p 值', '回归系数', 't 值', 'p 值', '回归系数', 't 值', 'p 值'], ['R', '0.480', '4.150', '0.000', '0.598', '3.196', '0.003', '0.404', '2.270', '0.028'], ['L', '-0.168', '-1.294', '0.203', '0.044', '0.253', '0.801', '-0.138', '-0.664', '0.510'], ['S', '0.892', '5.947', '0.000', '0.668', '2.710', '0.010', '0.910', '3.814', '0.000'], ['Adj R2', '0.693', '', '', '0.502', '', '', '0.580', '', ''], ['F', '34.861', '', '', '16.100', '', '', '21.726', '', '']]"
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 1.192809594081921,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.6347687605344946,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "从表4.10的结果可以看出，相关性分析及其检验结果显示，2010-2012年研发费用投入的回归系数都为正值，并且相关系数都通过了5%的显著性检验，说明研发费用投入与企业盈利能力显著正相关；2010-2012年技术人员数量的回归系数正负不同，并且相关系数都没有通过5%的显著性检验，说明技术人员数量与企业盈利能力不存在相关性。"
                        },
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.5580408335474263,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "同时，回归结果也说明了资产规模与企业盈利能力有显著的相关性，资产规模与企业盈利能力正相关，资产负债率与企业盈利能力。"
                        }
                      ]
                    },
                    {
                      "type": 1,
                      "outLvl": "",
                      "score": 0.7865268181337004,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "children": [
                        {
                          "type": 2,
                          "outLvl": "",
                          "score": 0.7865268181337004,
                          "selected": false,
                          "part": [],
                          "chosen": false,
                          "text_content": "从上述分组分析和模型分析中，我们可以看到，企业研发费用投入和研发投入强度与企业盈利能力显著正相关；但是企业技术人员的投入（技术人员数量和技术人员投入强度）与企业盈利能力之间没有显著的相关关系。"
                        }
                      ]
                    }
                  ]
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.3 企业研发投入与企业成长能力关系分析",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.9042097845717658,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.9042097845717658,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "首先，我们对企业研发投入与企业成长能力进行分组分析。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 2.24693963512701,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8197497895199513,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "如下表4.11所示，我们对不同研发投入强度下企业成长能力情况进行了分析，结果显示，在不同研发投入强度水平下，企业成长能力存在着较明显的差别，但没有一定的规律性。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.5615736133116208,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2011年、2012年企业平均营业收入增长率变动毫无规律性，2010年平均营业收入增长率在研发投入强度5%以下时逐渐增大，但超过5%以后平均营业收入增长率又开始下降。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8656162322954375,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "依据表中数据，我们认为医药制造企业研发投入强度与成长能力之间不存在明显的相关关系。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.741309117767051,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.741309117767051,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.11  不同研发强度下企业成长能力情况"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年度', '指标', '0-1%', '1%-3%', '3%-5%', '5%以上'], ['2010', '平均营业收入增长率', '14.93%', '20.94%', '22.41%', '22.13%'], ['2011', '平均营业收入增长率', '24.22%', '14.23%', '20.45%', '26.92%'], ['2012', '平均营业收入增长率', '23.01%', '27.18%', '20.07%', '20.92%']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 3.4188107950205193,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7418447069013748,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "如下表4.12所示，我们对不同技术人员投入强度下企业成长能力情况进行了分析，结果显示，在不同的技术人员投入强度下，企业成长能力存在较大的差别，但没有明显的规律性。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.562044617473739,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2012年随着技术人员投入强度的提高，企业平均营业收入增长率基本呈现逐渐的趋势，平均营业收入增长率由最初的18.51%上升到22.64%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6456962538393091,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "但分析2010年、2011年数据则会发现2012年出现的随着技术人员投入强度提高企业平均营业收入增长率下降的规律并不成立。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6467865549740379,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010年、2011年技术人员投入强度与企业平均收入增长率之间没有明显相关性。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8224386618320584,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "因此，我们认为医药制造企业技术人员投入强度与成长能力之间不存在明显的相关关系。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.8365301778924353,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8365301778924353,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "上述分析表明研发投入对企业成长能力不存在明显的促进作用，研发投入与企业成长能力没有相关关系。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7763129219511014,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7763129219511014,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.12  不同技术人员投入强度下企业成长能力分析"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年度', '指标', '0-10%', '10%-20%', '20%-30%', '30%以上'], ['2010', '平均营业收入增长率', '21.27%', '19.62%', '27.88%', '3.04%'], ['2011', '平均营业收入增长率', '17.69%', '24.04%', '13.69%', '25.17%'], ['2012', '平均营业收入增长率', '18.51%', '22.52%', '23.86%', '22.64%']]"
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.4 企业研发投入滞后性研究",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.24207338098401374,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.24207338098401374,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "在该研究中我们采用线性回归模型。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.9304790518652926,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.9304790518652926,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "医药制造企业第i年绩效与第i-j年的研发投入正相关："
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.10893842262792613,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.10893842262792613,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Y i =α0 +α1 RDI ij +α2 TPI ij +α3 S i +α4 ALT i +ε模型（3）"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.08951817576391995,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.08951817576391995,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "其中，Y表示产出变量，i表示年份(i=3)，j表示滞后期间(j=l, 2)，ε是为了消除其因素影响而引入的随机变量。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7857142857142857,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7857142857142857,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "1、前一期R&amp;D 投入对本期企业绩效的影响模型：Y 3 =α0 +α1 RDI 2 +α2 TPI 2 +α3 S+α4 ALT+ε"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.11119019157881488,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11119019157881488,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Y 3采用2012营业利润率衡量，RDI 2、TPI 2均采用2011年数据，S、ALT 采用"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.007553975539362696,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.007553975539362696,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010-2012年三年里资产总额自然对数的平均数、资产负债率的平均数。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7857142857142857,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7857142857142857,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2、前二期R&amp; D投入对本期企业绩效的影响模型：Y 3 =α0 +α1 RDI1 +α2 TPI1 +α3 S+α4 ALT+ε"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.11119019157881488,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.11119019157881488,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "Y 3采用2012营业利润率衡量，RDI1、TPI1均采用2010年数据，S、ALT 采用"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.007553975539362696,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.007553975539362696,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010-2012年三年里资产总额自然对数的平均数、资产负债率的平均数。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.1326290443096542,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.1326290443096542,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "运用SPSS16.0和EXCEL2003软件对数据进行处理，获得的回归结果如表4.13。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.8400694874726093,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8400694874726093,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.13  企业研发投入滞后性实证结果"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['', '滞后一期', '', '', '滞后两期', '', ''], ['', '回归系数', 't 值', 'p 值', '回归系数', 't 值', 'p 值'], ['研发投入强度', '1.366', '3.040', '0.004', '11.799', '3.730', '0.001'], ['技术人员投入强度', '0.393', '2.881', '0.006', '0.106', '0.582', '0.564'], ['资产规模', '0.073', '5.045', '0.000', '00.073', '4.804', '0.000'], ['资产负债率', '-0.406', '-5.219', '0.000', '-0.396', '-4.975', '0.000'], ['Adj R2', '0.602', '', '', '0.559', '', ''], ['F', '18.006', '', '', '15.250', '', '']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.597160967997911,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.597160967997911,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从表4.13的结果可以看出，滞后一期与滞后两期企业研发投入强度的回归系数都为正，且相关系数都通过5%显著性检验，但滞后两期的P值更小，说明相关性更强；滞后一期与滞后两期技术人员投入强度的回归系数都为正，但相关系数没有通过"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.059628559733535896,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.059628559733535896,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "5%的显著性检验，说明相关性不明显。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.22971644089640778,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.22971644089640778,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据表明，研发投入产出具有滞后性，且滞后两期的效果更显著。"
                }
              ]
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "1",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.5 本章研究小结",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6681046367610517,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6681046367610517,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "通过对上市医药制造企业研发投入与企业绩效的实证研究，我们可以看出："
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.37133595211201054,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.37133595211201054,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "1、我国上市医药制造企业整体研发费用投入不足，研发投入强度低，多年来上市医药制造企业研发投入强度均值都在5%以下；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.02222222222222222,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.02222222222222222,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2、医药制造企业技术人员投入强度较低，技术人员投入强度与欧美等发达国家医药企业相比还有很大差距；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6676626825848594,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6676626825848594,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3、医药制造企业研发费用、研发投入强度与企业营业利润（率）之间存在显著的正的相关关系；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.2505914311564041,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2505914311564041,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "4、医药制造企业技术人员投入强度与企业营业利润率存在不显著的正相关关系，技术人员数量与企业营业利润不存下显著地相关性；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7252136386816572,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7252136386816572,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "5、医药制造企业研发投入与企业绩效之间存在正的相关关系，这种相关关系在企业的盈利能力方面表现明显；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.29008590852192123,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.29008590852192123,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "6、医药制造企业研发投入强度、技术人员投入强度与企业营业收入增长率没有"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.539426342167491,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.539426342167491,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "相关关系，故医药制造企业研发投入与企业成长能力没有显著的相关关系；"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.2766851157877632,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2766851157877632,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "7、医药制造企业研发投入的效果具有一定的滞后性，且滞后两期的显著性更强。"
                }
              ]
            }
          ]
        }
      ]
    },
    {
      "type": 0,
      "outLvl": "1",
      "score": 0.0,
      "selected": true,
      "part": [
        "实证研究类v3"
      ],
      "chosen": false,
      "text_content": "4.1 描述性统计分析",
      "children": [
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": true,
          "part": [
            "实证研究类v3"
          ],
          "chosen": false,
          "text_content": "4.1.1 研发投入的描述性统计分析",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 0.6790241026041812,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6790241026041812,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "通过严格的筛选，符合本文研究要求的样本企业共46家。从下表4.1研发费用投"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.3224939930135596,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3224939930135596,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "入描述性统计分析中我们可以看到2010至2012年研发费用投入最小值、最大值、均值三个指标数据不断提高。2010 年研发费用投入的最大值为27200 万元，均值为"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.2189910345958932,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.2189910345958932,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3761.35万元；2012年研发费用投入的最大值为36989万元，均值为6089.29万元。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.9938889040043228,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.1849384546100398,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "3年中研发费用投入的最大值增长了9789万元，增长了35.99%；均值增长了2327.94万元，增长了61.89%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.8089504493942831,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表明我国医药制造企业研发费用投入不断提高。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.25561680384606583,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.25561680384606583,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "年的研发费用投入为96.46亿美元，第2位的辉瑞为94.13亿美元，第3位的诺华为"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7572144460711278,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.0002498251637833238,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "90.70亿美元。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7569646209073444,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "三家公司研发投入都超过90亿美元（约合5590980万元），诚然有企业规模差距的原因，但也从一定程度上说明我国医药制造企业研发费用投入与国际大型医药企业还有很大差距，仍应提高研发投入。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.428802124622074,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6888447060008579,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "46家医药制造企业2010年研发费用投入的标准差为4632.13, 2012年研发费用投入的标准差为7331.01, 3年中研发费用投入标准差增长了2698.88，增长了58.26%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.739957418621216,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表明我国医药制造企业间研发费用投入差距不断扩大，诚然有市场环境、资产规模、资产结构等原因，但也提醒相关企业应重视科研投入，从而提高核心竞争力。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.44161923395933,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.44161923395933,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.1  研发费用投入描述性统计分析"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年份', '最小值万元）', '最大值万元）', '均值万元）', '标准差', '样本数'], ['2010', '163.37', '27200.00', '3761.35', '4632.13', '46'], ['2011', '145.75', '31287.00', '4417.44', '5354.53', '46'], ['2012', '296.48', '36989.00', '6089.29', '7331.01', '46']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.7164619600594135,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7164619600594135,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从下表4.2研发投入强度描述性统计分析，可以看到，我国医药制造企业整体研发强度不高，2010年研发强度均值只有4.07%，3年中研发强度均值最高出现在2012年，也仅为4.52%。据英国贸易和工业部2005年发布的数据显示医药产业研发投入强"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.367726686933942,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6566006072235399,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "度在所有产业中最高，研发强度为15%,由此可见我国医药制造企业研发强度与国际相比还有很大差距。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7111260797104021,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "但从2010年至2012年研发投入强度均值的发展趋势上，我们可以看到它是逐渐上升的，研发强度均值由4.07%增加到4.52%，增长了0.45个百分点，表明医药制造企业研发投入强度不断提升，企业更加注重研发投入。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.4016038042983106,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.667573286263337,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从研发投入强度的标准差指标中，我们可以看到医药制造企业间研发投入强度的差距较大，2010年研发投入强度的标准差为2.84%，2012年研发投入强度的标准差已达3.31%，研发投入强度标准差相距0.47%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7340305180349735,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据说明医药制造企业间研发投入强度差距较大，可能的原因是国内有些医药制造企业开始摆脱仿制药物的发展模式，走上新药研发创新的新路，加大了研发投入在营业收入中的比重，而有些企业依然在走药物仿制的老路，医药研发投入强度没能提升。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.44419358704163986,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.44419358704163986,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.2  研发投入强度描述性统计分析"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '0.16%', '15.26%', '4.07%', '2.84%', '46'], ['2011', '0.28%', '12.66%', '4.12%', '2.80%', '46'], ['2012', '0.46%', '17.07%', '4.52%', '3.31%', '46']]"
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.1.2 技术人员的描述性统计分析",
          "children": [
            {
              "type": 1,
              "outLvl": "",
              "score": 1.2137044657121505,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.22069331577248807,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从下表4.3技术人员描述性统计分析中我们可以看到2010至2012年技术人员数量最大值、均值两个指标数据不断提高。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.06851588149435132,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010年技术人员数量最大值为1667，均值为249.24; 2012年技术人员数量最大值为2326，均值为377.89.3年中技术人员数量最大值增长了659，增长了39.53%；均值增长了128.65，增长了51.62%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6368291468593998,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表明我国医药制造企业技术人员数量在不断增加。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.28766612158591126,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "与同期研发投入费用的增长幅度相比则显得增速比较低，可能是因为随着我国经济的不断发展，人均工资不断提高导致。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.9776415844746259,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.48845066756139244,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "46家医药制造企业2010年技术人员数量的标准差为327.88, 2012年技术人员数量的标准差为447.81, 3年中技术人员数量标准差增长了119.93，增长了36.58%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.48919091691323346,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "2010年技术人员数量的最小值为14，最大值为1667，最大值与最小值相差1653, 2012年技术人员数量的最大值最小值相差2291，表明我国医药制造企业间技术人员数量差距很大，并且有不断扩大的趋势。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.23513593194859367,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.23513593194859367,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.3  技术人员描述性统计分析"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '14', '1667', '249.24', '327.88', '46'], ['2011', '4', '1923', '310.35', '404.08', '46'], ['2012', '35', '2326', '377.89', '447.81', '46']]"
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.3740511818254812,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6701266851054961,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从下表4.4技术人员投入强度描述性统计分析，可以看到，我国医药制造企业技术创新人员投入严重不足，2010年技术人员投入强度均值只有14.01%，3年中技术人员投入强度均值最高出现在2012年，也仅为16.66%。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.7039244967199851,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "数据显示，欧美日等发达国家的医药企业中R&amp;D活动人员占到企业从业人员的30%左右，而本文技术人员为包括研发人员在内的所有技术人员，且技术人员投入强度仅约为发达国家医药企业研发人员投入强度的一半，说明我国医药制造企业研发人员投入不足。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 1.2234495490402484,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.592030021068985,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "从技术人员投入强度的标准差指标中，我们可以看到医药制造企业间技术人员投入强度差距逐渐拉大，2010年技术人员投入强度的标准差为7.26%，2012年技术人员投入强度的标准差达3年中最高为9.37%，3年来技术人员投入强度标准差逐渐加大，说明医药制造企业间技术人员投入强度逐渐加大。"
                },
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.6314195279712634,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "然而，3年中技术人员投入强度的最小值与最大值保持30%以上的差距，2011年及2012年两者差距甚至超过了40%，说明医药制造企业间研发人员投入强度差距还比较大，应进一步缩小这种差距，提高研发人员投入强度。"
                }
              ]
            },
            {
              "type": 1,
              "outLvl": "",
              "score": 0.3233426547181023,
              "selected": false,
              "part": [],
              "chosen": false,
              "children": [
                {
                  "type": 2,
                  "outLvl": "",
                  "score": 0.3233426547181023,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "text_content": "表4.4  技术人员投入强度描述性统计分析"
                }
              ]
            },
            {
              "type": 3,
              "outLvl": "",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "table_data": "[['年份', '最小值', '最大值', '均值', '标准差', '样本数'], ['2010', '0.78%', '31.47%', '14.01%', '7.26%', '46'], ['2011', '0.26%', '41.44%', '15.32%', '8.77%', '46'], ['2012', '2.21%', '43.58%', '16.66%', '9.37%', '46']]"
            }
          ]
        },
        {
          "type": 0,
          "outLvl": "2",
          "score": 0.0,
          "selected": false,
          "part": [],
          "chosen": false,
          "text_content": "4.1.3 分组分布特征",
          "children": [
            {
              "type": 0,
              "outLvl": "3",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.1.3.1 研发投入强度的分组分布特征",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.4440819727231695,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6784095833352403,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "研发投入强度是衡量一个企业技术能力和核心竞争力的重要指标。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7656723893879293,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "相关研究表明，研发投入强度不足1%的企业，生存难以为继；达到2%的企业只能勉强维持生存；超过3%，但不足5%的企业，仅仅是可以正常运营；只有研发投入强度超过5%，企业才具有了竞争能力。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.6264811809003297,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6264811809003297,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "业达到10%，有些企业甚至达到20%。据统计，2006 年美国医药企业研发投入高达"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.3255204669167122,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.3255204669167122,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "552亿美元，美国医药企业平均研发强度为25.93%；2005年日本主要医药企业平均研发投入为6亿美元，研发强度为18%；德国医药企业先灵、柏林格、拜耳每年的研究与开发经费都在11-12亿美元水平，研发强度在10%-20%之间。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.6336397249696377,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6336397249696377,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "但从表4.5中我们可以看出：2010-2012年研发投入强度不足1%的企业占样本总数的一成多，比较稳定；研发投入强度不足3%的企业比例逐年下降，2010年比例为"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 1.2887613070764399,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5204707979775238,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "34.78%，2011年比例为32.61%，2012年比例为28.26%；研发强度超3%的企业比例逐年上升，由2010年的65.22%上升到2012年的71.74%，但研发强度超5%的企业比例基本保持稳定。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.7682905090989159,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "数据说明，研发投入能维持正常运营以上水平的医药制造企业比例逐渐提高，从而说明医药制造企业研发投入逐年提高，但是依靠研发投入提高竞争力的企业比例基本稳定，说明依靠研发投入提高竞争力的做法并没有在我国医药制造企业中进一步使用。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.36726685865847897,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.36726685865847897,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.5  研发投入强度分组"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年度', '0-1%', '1%-2%', '2%-3%', '3%-4%', '4%-5%', '5%以上'], ['2010', '10.87%', '10.87%', '13.04%', '21.74%', '13.04%', '30.43%'], ['2011', '15.22%', '4.35%', '13.04%', '19.57%', '21.74%', '26.09%'], ['2012', '13.04%', '2.17%', '13.04%', '28.26%', '15.22%', '28.26%']]"
                }
              ]
            },
            {
              "type": 0,
              "outLvl": "3",
              "score": 0.0,
              "selected": false,
              "part": [],
              "chosen": false,
              "text_content": "4.1.3.1 技术人员投入强度的分组分布特征",
              "children": [
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 2.982471650555437,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5552717960524682,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "企业中技术人员所占企业总员工的比例并不是越多越好，技术人员投入强度多大为最佳，迄今并没有统一的认识。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5386381480541514,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "2001年科技部颁发的《国家高新技术产业开发区高新技术企业认定条件和办法》第五条高新技术企业认定条件的第三款中，我们可以看出，具有大专以上学历的科技人员占企业职工总数的30％以上是企业被界定为高新技术企业的一个必备条件。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.5855216885468988,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "然而，从下表4.6中，我们可以看到2010年技术人员投入强度在30%以上的企业比例仅为2.17%；2011年技术人员投入强度超30%的企业比例最高，但仅为13.04%。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6601973292195943,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "3年中技术人员投入强度超过30%的企业占样本总数的比例都很低，从严格意义上来说，多数上市医药制造企业并不符合高新技术企业的条件。"
                    },
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.6428426886823243,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "另一方面，我们看到技术人员投入强度在20%以上的企业比例3年中在不断提高，2010年为19.57%，2011年为21.74%，2012年为226.09%，说明医药制造企业更注重技术人员的引进。"
                    }
                  ]
                },
                {
                  "type": 1,
                  "outLvl": "",
                  "score": 0.2502182650885446,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "children": [
                    {
                      "type": 2,
                      "outLvl": "",
                      "score": 0.2502182650885446,
                      "selected": false,
                      "part": [],
                      "chosen": false,
                      "text_content": "表4.6  技术人员投入强度分组"
                    }
                  ]
                },
                {
                  "type": 3,
                  "outLvl": "",
                  "score": 0.0,
                  "selected": false,
                  "part": [],
                  "chosen": false,
                  "table_data": "[['年度', '0-10%', '10%-20%', '20%-30%', '30%以上'], ['2010', '28.26%', '52.17%', '17.39%', '2.17%'], ['2011', '26.09%', '52.94%', '8.70%', '13.04%'], ['2012', '23.91%', '50.00%', '15.22%', '10.87%']]"
                }
              ]
            }
          ]
        }
      ]
    }
  ]
}